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ABSTRACT 
Burden of Illness among Elderly Individuals with Parkinson’s disease 
Sandipan Bhattacharjee, B. Pharm., M.S. 
 
Parkinson‟s disease (PD) is the second most common neurodegenerative disease affecting an 
estimated one million individuals in the United States (U.S.) and five million individuals 
globally. With increasing age, the prevalence of PD also increases. Challenges of PD include 
high economic burden of formal care, informal caregiving burden, and also management of a 
chronic illness (e.g. type 2 diabetes mellitus) in the presence of PD. The purpose of this study 
was to use observational data from real-world settings to provide a comprehensive view of the 
burden of illness among elderly individuals with PD by assessing the formal economic burden, 
informal caregiving burden and the state of management of chronic illness with complexity 
(CIC) in the presence of two debilitating conditions (PD and type 2 diabetes mellitus). This study 
used a triangulation approach by using three different datasets: (i) National Medicare 5% sample 
claims database to evaluate the formal economic burden; (ii) the National Alliance for 
Caregiving (NAC) data to assess the informal caregiver burden; and (iii) the nationwide claims 
database of Humana Medicare Advantage Part D enrollees to evaluate the state of management 
of chronic illness with complexity. The specific aims of the three studies were: (1) among elderly 
Medicare beneficiaries aged 65 or older, estimate excess home healthcare use and expenditures 
among individuals with PD compared to individuals without PD and analyze predisposing, 
enabling, need factors, personal health behaviors, and external environment associated with 
excess home healthcare use and expenditures among individuals with PD; (2) assess the informal 
caregiver burden and estimate costs associated with informal caregiving burden among 
caregivers providing care to elderly individuals; and (3) assess process, and intermediate clinical 
outcomes of diabetes care among individuals with chronic illness with complexity defined as co-
occurring PD and diabetes. From the results of the first study, we found that elderly Medicare 
beneficiaries with PD had significantly higher home healthcare use and expenditures compared 
to those without PD. The differences in home healthcare use and expenditures among elderly 
Medicare beneficiaries with and without PD were mainly explained by personal health behaviors 
such as baseline resource use and need factors such as physical and mental health conditions. In 
terms of the economic burden of informal caregiving, we did not observe a significant difference 
in informal caregiving costs between caregivers of elderly individuals with and without PD, 
despite the costs of informal caregiving for elderly individuals with PD being 1.27 times higher 
than those without PD. Individuals with CIC were less likely to achieve American Diabetes 
Association recommended annual HbA1c and lipid testing goals compared to those without CIC 
(T2DM without PD). However, individuals with CIC achieved glycemic and lipid control 
outcomes. Thus, these findings taken together underscore the advantage of using an integrated 
delivery system with better care coordination and providing “holistic care approach.” As 
majority of elderly individuals with PD are community-dwelling, novel intervention techniques 
are needed to be developed to reduce the informal caregiving burden. 
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Prevalence of Parkinson’s disease 
Parkinson‟s disease (PD) is the second most common neurodegenerative disease affecting 
an estimated one million individuals in the United States (U.S.) and 5 million individuals 
globally (Olanow, Stern, & Sethi, 2009). With increasing age, the prevalence of PD also 
increases. The prevalence of PD is estimated to be 1% among individuals 60 years or older 
(Olanow et al., 2009) and it increases to 4% among individuals 80 or older (Terriff et al. 2012). It 
has also been projected that there will be a two-fold increase in the number of individuals with 
PD by 2030 (Dorsey, 2007). In the US, projections indicate a substantial increase in the number 
of elderly individuals (baby-boomers) and as the prevalence of PD increases with age, it is 
important to study the healthcare management of elderly individuals in order to achieve better 
health outcomes and decrease the steeply rising cost curve among this population. 
Parkinson’s disease and economic burden among elderly 
It has been observed that despite the low prevalence of PD, individuals with PD 
experience substantially higher healthcare expenditures compared to those without PD (Noyes et 
al., 2006; Olanow, Stern, & Sethi, 2009). In the United States (U.S.), a nationally representative 
study of Medicare beneficiaries found that the average healthcare expenditures among 
individuals with PD were approximately twice as high as those without PD (Noyes et al., 2006). 
As the prevalence of elderly individuals is estimated to rise significantly over the next couple of 
decades, there will be a consequent increase in the prevalence of individuals with PD. As the 
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elderly individuals with PD experience high economic burden due to their disease state, the 
increase in the prevalence of elderly individuals with PD can be a major public health concern. 
Parkinson’s disease and home healthcare 
Limitations of ADLs, IADLs, motor and non-motor symptoms, cognitive impairment, 
behavioral issues and greater need for home health care among individuals with PD can lead to 
greater caregiving needs for individuals with PD. This has also translated into higher home 
healthcare use and expenditures among individuals with PD. Indeed, in all the studies that have 
compared healthcare expenditures among individuals with and without PD (Bhattacharjee & 
Sambamoorthi, 2013; Noyes et al., 2006; Pressley et al., 2003; Rubenstein, Chrischilles, & 
Voelker, 1997), a consistent finding has been greater home healthcare expenditures among 
individuals with PD compared to those without PD. However, none of these studies has 
systematically examined the contributors to excess home health expenditures among individuals 
with PD. This study extends previous studies by not only providing estimates of formal and 
informal caregiving but examining the factors that contribute to excess formal caregiving 
expenditures by analyzing the individual-level factors associated with them. 
This provides the rationale for our Aim 1, which estimates the excess home healthcare 
use and expenditures associated with PD and examine factors associated with this excess use and 
expenditures. This study aim was accomplished by conducting a comparative analysis of 
individuals with and without PD. This aim further quantifies the extent to which each of the 
different set of factors can explain excess home healthcare expenditures among individuals with 
PD compared to those without PD.   
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Parkinson’s disease and informal care giver burden 
In addition to formal home healthcare, individuals with PD also rely on home healthcare 
provided by informal caregivers. As the majority of elderly individuals with PD live in 
communities, caregiving is mainly provided by spouse or children of individuals with PD (Lau 
2011). When caregiving is provided by close family members, relatives, or friends who do not 
have any organizational affiliations or certificates for caregiving they are considered as informal 
caregivers (Rakoski, 2012). Some studies have documented that caregivers of PD suffer from 
substantial caregiving burden because of fear or uncertainty, shift in roles, financial burden, 
social isolation, little time alone, demands of constant care and feel of guilt. In fact, many 
informal caregivers spend on an average 96 hours/week providing care to individuals with PD 
(Parish 2003).  
This leads us to Aim 2, which was to assess caregiver burden of individuals providing 
care to elderly (age ≥ 65 years) individuals with PD compared to caregivers of elderly 
individuals without PD and to estimate costs associated with providing informal care to elderly 
individuals with PD compared to informal caregiving of elderly individuals without PD. 
Parkinson’s disease and diabetes 
 One of the drivers of formal and informal home healthcare use and expenditures is the 
presence of complexity in PD. Individuals with PD can have co-occurring chronic conditions 
including type 2 diabetes mellitus (T2DM), which may increase economic and morbidity burden. 
Of specific importance is the presence of T2DM and PD because co-occurring T2DM among 
individuals with PD is associated with substantially (over five times) higher home healthcare 
expenditures compared to matched controls without PD but with diabetes (Bhattacharjee & 
Sambamoorthi 2013). In addition, biological and epidemiological connections between T2DM 
and PD have been considered, although the relationship remains inconclusive. Furthermore, 
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studies on diabetes care among individuals with multimorbidity have not proven that guideline-
consistent diabetes care can actually improve quality and outcomes of care (Woodard, Urech, 
Landrum, Wang, & Petersen, 2011; Fischer et al., 2000).  
Therefore, it is important to assess the state of diabetes care among individuals with PD 
and the association between CIC and outcomes and quality of diabetes care. This provides the 
rationale for our Aim 3, which is to assess process, outcomes, and quality of diabetes care among 
individuals with chronic illness with complexity defined as co-occurring PD and diabetes.  
As PD has a higher prevalence among elderly (≥ 65 years) than among other age groups, 
most of these individuals will be eligible for Medicare. Therefore, most of healthcare spending 
will be borne by Medicare. Although less than 5% of total spending was for home health care, 
Medicare home healthcare spending has grown substantially over the past decade. Indeed, in 
2010, Medicare spending on home healthcare was estimated at $19.4 billion (Health Care 
Spending-Medicare). Because of the escalating home healthcare expenditures Centers for 
Medicare and Medicaid Services (CMS) has been exploring ways to reduce the excess home 
healthcare expenditures.  It has been estimated that individuals with PD accounts for a significant 
portion of home healthcare visits (National Home and Hospice Care Survey, 2011). Therefore, 
an understanding of factors contributing to home healthcare among all elderly and specifically 
those with PD who are high utilizers of home healthcare is critical. 
Although individuals with PD rely on formal home healthcare, informal care continues to 
be one of the main components of home health care received by individuals with PD. Care givers 
of individuals with PD often suffer from poor quality of life, financial burden, social isolation, 
little time alone, demands of constant care and feel of guilt. Some studies have evaluated 
informal caregiver burden among individuals with PD. These studies are limited by geographical 
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locations within the U.S. (Edwards & Ruettiger, 2002). Many of these studies are outdated with 
data from as early as1999 (Parrish et al., 2003). Additionally, none of these studies estimated 
costs associated with informal caregiving among caregivers of individuals with PD. As the 
number of elderly individuals as well as those with PD are expected to increase substantially 
over the next decade, it can also be expected that there will be higher needs for informal 
caregiving for these aging population. In this context, it is important to identify caregivers who 
are at high risk for high care burden so that programs and interventions can be developed to 
improve the well-being of the caregivers. 
As stated before, chronic illness with complexity is a major issue among individuals with 
PD because of the prevalence of other chronic conditions including diabetes. Almost all clinical 
practice guidelines are developed based on the expert consensus and the scientific evidence for a 
single disease state (Boyd et al., 2005) rather than for multiple conditions. There are separate 
guidelines for treating diabetes (such as the guidelines of the American Diabetes Association) 
and PD (European Parkinson's Disease Standards of Care Consensus Statement). Therefore, it is 
not known as to whether guideline consistent care is provided to individuals with co-occurring 
chronic conditions and so it is important to explore the current state of standards of care and 
health outcomes among individuals with co-occurring chronic conditions such as T2DM and PD. 
PURPOSE OF THIS STUDY 
 The purpose of this study was to use observational data from real-world settings to 
provide a comprehensive view of the burden of illness among elderly individuals with PD by 
assessing the economic burden, informal caregiving burden and the state of management of 
chronic illness with complexity in the presence of two debilitating conditions (PD and type 2 
diabetes mellitus). This study used a triangulation approach by using data from different sources 
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to answer the specific aims as there is no single data available that consists of all the variables 
used in this study. We used the National Medicare 5% sample claims database to evaluate the 
economic burden. To assess the informal caregiver burden, we used the nationally representative 
sample of National Alliance for Caregiving (NAC) data. To evaluate the state of management of 
chronic illness with complexity, we used the nationwide sample of Humana Medicare Advantage 
Part D enrollees.  
Aim 1: Among elderly Medicare beneficiaries aged 65 or older, estimate excess home 
healthcare use and expenditures among individuals with PD compared to individuals 
without PD and analyze predisposing, enabling, need factors, personal health behaviors, 
and external environment associated with excess home healthcare use and expenditures 
among individuals with PD. 
 
Objective 1.1:  Among elderly Medicare beneficiaries aged 65 or older, estimate excess 
home healthcare use among individuals with PD compared to individuals without PD.   
 
Hypothesis 1.1: We hypothesized that elderly Medicare beneficiaries with PD will be more likely 
to have home healthcare use compared to those without PD after adjusting for predisposing 
(age, gender, race/ethnicity), enabling (public assistance), need [(co-occurring chronic 
conditions), healthcare use (baseline healthcare use)], personal health behaviors (substance use, 
baseline resource use), and external environmental (census region, metro-status) factors. 
 
Aim 1.2:  Among elderly Medicare beneficiaries aged 65 or older and among users of home 
healthcare, estimate excess home healthcare expenditures among individuals with PD 
compared to individuals without PD.  
 
Hypothesis 1.2: We hypothesized that home healthcare expenditures among individuals with PD 
will be higher compared to those without PD after adjusting for predisposing (age, gender, 
race/ethnicity), need (co-occurring chronic conditions), personal health behaviors (substance 
use disorders, baseline resource use), and external environmental (census region, metro-status) 
factors.  
 
Objective 1.3: Analyze the extent to which differences in predisposing, enabling, need 
factors, personal health behaviors, and external environment characteristics between PD 
and no PD groups contribute to the excess home healthcare use and expenditures among 
elderly Medicare beneficiaries with PD. 
 
Hypothesis 1.3: We hypothesized that differences in need factors as measured by co-occurring 
chronic condition will explain higher rates of home healthcare use and expenditures among 
elderly Medicare beneficiaries with and without PD. 
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Aim 2: Assess the informal caregiver burden and estimate costs associated with informal 
caregiving burden among caregivers providing care to elderly individuals (age ≥ 65 years).  
 
Objective 2.1: To assess caregiver burden of individuals providing care to elderly care-
recipients with PD compared to caregivers of elderly care-recipients without PD.  
 
Hypotheses 2.1: We hypothesized that informal caregivers of individuals with PD will have 
higher burden compared to the caregivers of individuals without PD after adjusting for care-
recipient and caregiver characteristics.  
 
Objective 2.2: To estimate costs associated with providing informal care to elderly 
individuals with and without PD.  
 
Hypotheses 2.2: We hypothesized that costs of providing informal care to individuals with PD 
will be higher than costs of providing informal care to individuals without PD after adjusting for 
care-recipient and caregiver characteristics. 
 
Aim 3: To assess process and intermediate clinical outcomes of diabetes care among 
individuals with chronic illness with complexity defined as co-occurring PD and diabetes. 
 
Objective 3.1: Evaluate diabetes process of care among elderly individuals with CIC 
(T2DM and PD) compared to those without CIC (T2DM and no PD) within a multivariate 
framework.  
Hypothesis 3.1: We hypothesized that the process of diabetes will be poor among elderly 
individuals with CIC (T2DM and PD) compared to those without CIC (T2DM without PD) 
within a multivariate framework. 
 
Objective 3.2: Examine intermediate clinical outcomes among elderly individuals with CIC 
(T2DM and PD) compared to those without CIC (T2DM without PD) within a multivariate 
framework. 
Hypothesis 3.2: We hypothesized that the intermediate clinical outcomes will be poor among 
elderly individuals with CIC (T2DM and PD) compared to those without CIC (T2DM without 
PD) within a multivariate framework. 
 
SIGNIFICANCE OF THE STUDY 
 The present study makes a unique contribution to the knowledgebase by evaluating 
economic burden, informal caregiver burden and the state of management of chronic illness with 
complexity with two debilitating diseases (PD and type 2 diabetes mellitus) of individuals with 
PD and caregivers of PD. To the best of our knowledge, no study till date has been conducted to 
provide a holistic view of PD healthcare management by focusing on all these different aspects. 
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Moreover, as the population of United States is aging, these studies are timely and appropriate as 
they focus on an aging problem such as PD, which may become a major public health concern in 
the near future. Furthermore, the datasets used for each of the specific aims of this dissertation is 
a nationally representative or nationwide data. Till date, there are no studies available that have 
used a nationally representative or nationwide data to answer these research questions from 
home healthcare perspective. Using observational data from real-world settings, this dissertation 
will fill this critical knowledge gap on the economic burden, caregiver burden and the state of 
management of chronic illness with complexity among elderly individuals with PD by providing 
estimates at national level.  
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CHAPTER 2: Home Care Use and Expenditures and Parkinson’s disease among Elderly 
Medicare Beneficiaries: An Application of Decomposition Technique 
                        
INTRODUCTION 
Parkinson’s disease and home healthcare expenditures 
Despite the low prevalence of Parkinson‟s disease (PD) (approximately 1-2% in 
individuals 60 years or older), individuals with PD experience substantially higher healthcare 
expenditures compared to those without PD (Noyes, Liu, Li, Holloway, & Dick, 2006; Olanow, 
Stern, & Sethi, 2009).  Specifically, home healthcare expenditures have been observed to be 
consistently and substantially higher among individuals with PD compared to those without PD 
(Bhattacharjee & Sambamoorthi, 2013; Noyes et al., 2006; Pressley et al., 2003; Rubenstein, 
Chrischilles, & Voelker, 1997).  The magnitude of the difference varied depending on the year in 
which the studies were conducted. Using data from Medicare Current Beneficiary Survey 
(MCBS) it has been reported that average annual home healthcare expenditures among  elderly 
Medicare beneficiaries with PD (US$1,422) was 3.2 times as high as home healthcare 
expenditures compared to those without PD (US$448) expressed in 2002 US dollars (Noyes et 
al., 2006). Another recent study conducted using Medical Expenditure Panel Survey data on 
community-dwelling elderly individuals aged 65 years or older living in the U.S., which used 
propensity score matching to derive no PD group, found that individuals with PD had 
approximately 2.5 times higher home healthcare expenditures ($2,559)  compared to those 
without PD ($1,017) expressed in 2009 dollars (Bhattacharjee & Sambamoorthi, 2013). Among 
users of home healthcare, similar differences were found between elderly individuals with and 
without PD. 
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PD and home healthcare use 
 
Home healthcare use has also been shown to be higher among elderly with PD compared 
to those without PD. Rates of home healthcare use among community-dwelling Medicare 
beneficiaries with PD were 3.5 times as high as those without PD (Noyes et al., 2006). Among 
community-dwelling and institutionalized elderly (age 65 years or older) Medicare beneficiaries 
participating in the National Long-Term Care Survey (NLTCS), it was observed that home 
healthcare use among Medicare beneficiaries with PD was two times as high as those without 
PD. This study suggested that the presence of co-occurring conditions contributed to higher use 
of home healthcare services among individuals with PD compared to those without PD (Pressley 
et al., 2003). Unpublished data from the authors (Bhattacharjee & Sambamoorthi, 2013) revealed 
that home healthcare use among individuals with PD was two times as high as those of 
propensity-score matched individuals without PD. 
Factors associated with home healthcare use and expenditures 
Higher home healthcare use and expenditures among elderly with PD can be due to many 
factors. PD is characterized by bradykinesia (difficulty or slowness of starting movements), 
resting tremors (shaking of limbs involuntarily), rigidity (stiffness of arms, legs, and/or neck), 
and imbalance (Park & Stacy, 2009; Vickers & O'Neill, 1998). These physical conditions can 
lead to difficulties in carrying out activities of daily living (ADLs) and instrumental activities of 
daily living (IADLs). Common geriatric issues such as medication management is particularly 
challenging in PD population because of “on-off” phenomenon with medication therapies. 
Additionally, individuals with PD may require greater surveillance at home to monitor the side-
effects of antiparkinsonian (APD) medications, decline in effectiveness of APD medications and 
Page 22 of 129 
 
worsening of PD symptoms (Vickers & O'Neill, 1998). Moreover, APDs can induce cognitive 
decline, which may require careful monitoring at home (Moore & O'Keeffe, 1999). Furthermore, 
home healthcare professionals are required for individuals with PD to alter their diet, understand 
sleep cycle disturbances and teach newer techniques to execute ADLs and IADLs (Vickers & 
O'Neill, 1998). While all these problems are common among many elderly, PD presents 
particular challenges. For example, findings from a study that compared functional problems 
experienced by caregivers and care-recipients suggested that those with PD have greater home 
healthcare needs (Parrish, Giunta, & Adams, 2003) compared to other cognitively impaired 
(stroke, Alzheimer‟s disease, multi-infarct dementia, other degenerative disease/dementia, 
traumatic brain injury, brain tumor, other non-degenerative disease, multiple sclerosis, 
amyotrophic lateral sclerosis, or unreported diagnosis) individuals. According to this study, PD 
care-recipients reported on an average 10 functional problems which included difficulties in 
ADLs (eating, bathing, dressing, toileting, transferring), and IADLs (taking medication, 
performing household chores, managing money/finances). 
Although not specific to PD, previous literature suggests that limitations of ADL, IADL, 
cognitive impairment, older age, as well as co-occurring chronic diseases were associated with 
higher home healthcare use (Fortinsky, Fenster, & Judge, 2004; Henton, Hays, Walker, & 
Atwood, 2002; Moon & Shin, 2006). A study conducted among Medicare-Medicaid dual eligible 
using data from Connecticut Long Term Care Health (CLTC) between the time period of August 
1995 to December 1997 found that higher limitations of activities of daily living (ADLs), 
dependence in walking and climbing stairs, and mild cognitive impairment were statistically 
significantly associated with higher Medicare home healthcare use and expenditures (Fortinsky 
et al., 2004). Using data from 1996 Medical Expenditure Panel Survey (MEPS), it was observed 
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that among elderly individuals (aged 65 years or older) being old-old, non-white, and having 
greater functional limitations were associated with higher per-capita annual Medicare home 
healthcare expenditures (Henton et al., 2002). Another study using data from 1996-2000 MEPS 
among Medicare-Medicaid dual eligible population found that poor health and co-occurring 
chronic diseases were significantly associated with higher home healthcare use (Moon & Shin, 
2006).   
Need for the study 
As PD has a higher prevalence among elderly (≥ 65 years) than among other age groups, 
most of these individuals are eligible for Medicare. Therefore, most of home healthcare spending 
will be borne by Medicare. Indeed, in 2010, Medicare spending on home healthcare was 
estimated at $19.4 billion (Health Care Spending-Medicare). Although less than 5% of total 
spending was for home health care, Medicare home healthcare spending has grown substantially 
over the past decade.  It has been estimated that total Medicare home healthcare expenditures 
increased from by 129% between 2000 and 2010 (Home Healthcare Services-Chapter 8). This 
steep increase has been partly attributed to the aging population of the United States (U.S.). The 
number of home healthcare users also increased from 2.5 million to 3.4 million between 2002-
2010 (Health Care Spending-Medicare).  
According to the 2007 National Home and Hospice Care Survey (NHHCS), diabetes 
(10.1%), diseases of central nervous system (8.4%), were the top two common primary 
diagnoses at the time of home healthcare visit (National Health Statistics Report 2011). Among 
diseases of the central nervous system, nearly 15% of the home healthcare visits were for 
individuals with PD. Because of the escalating home healthcare expenditures Centers for 
Medicare and Medicaid Services (CMS) has been exploring ways to reduce the excess home 
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healthcare expenditures. Thus, an understanding of factors contributing to home healthcare 
among all elderly and specifically those with PD who are high utilizers of home healthcare is 
critical. However, to the best of authors‟ knowledge, no study has analyzed various factors 
associated with higher home healthcare use and expenditures among individuals with PD. 
Therefore, the primary purpose of the study was to estimate excess home healthcare use and 
expenditures associated with PD and examine factors associated with excess use and 
expenditures.  
The current study further highlighted the extent to which each of the different set of 
factors explain excess home healthcare use and expenditures among individuals with PD 
compared to those without PD.  The current study used data on 5% sample of nation-wide fee-
for-service Medicare beneficiaries.  
Medicare and Home Healthcare 
 As the current study focuses on elderly Medicare beneficiaries, we briefly describe the 
eligibility requirements to receive Medicare paid home healthcare services, as well as the 
services covered under Medicare. To be eligible to receive home healthcare services an elderly 
Medicare beneficiary must satisfy the following criteria: (1)  need of a part-time (less than 8 
hours/day) or sporadic skilled care (care obtained from a nurse, physical, or speech therapist); (2) 
not able to leave their house without help from others or without considerable self-effort; (3) 
certification from a physician stating the need for home healthcare; and (iv) home healthcare 
should be provided according to a care plan established by a physician, and the care should also 
be regularly reviewed by the physician.  
Starting in 2000, the CMS adopted a prospective payment system (PPS) which pays for 
home healthcare in a 60-day episode at a predetermined rate. The payment rates are adjusted in 
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terms of severity of the beneficiary (condition of the beneficiary and service use) and also to 
reflect the level of market input prices based on the geographical area of service delivery 
(MedPAC payment basis). The severity of beneficiaries is calculated on the basis of case-mix 
index that depends on the beneficiaries‟ clinical and functional characteristics as well as certain 
services that they might use. In case of less than 5 visits during a 60-day episode, the home 
health agency is reimbursed on the basis of visit rather than by type of visit. The payments are 
also modified under certain circumstances as for instance when there are high-cost outliers. After 
the end of the initial 60-day period, if further home healthcare service is needed then that is 
counted as a new episode (Home Healthcare Services-Chapter 8).  
Conceptual Framework 
The conceptual behavioral model by Andersen was used to examine the predisposing, 
enabling, need, personal health choices and external environmental factors associated with the 
healthcare expenditures (Andersen, 1995). The Andersen Behavioral Model (ABM) has been 
used in various studies related to usage of health services (both healthcare use and expenditures). 
The ABM posits an individual‟s use of health services as a function of (1) predisposing, (2) 
enabling, (3) need factors, (4) personal health choices and (5) external environment. The 
individual‟s characteristics that are predisposing include demographic characteristics (e.g. 
gender, age, race/ethnicity). The ability of an individual to access a health service is termed as an 
enabling factor (e.g. public assistance). Need factors are represented by a subjective 
acknowledgement of need such as a patient‟s symptoms, or a professional‟s judgment of the 
need for healthcare based on disease characteristics. Personal health choices and external 
environment characteristics also influence an individual‟s use of health services.  
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Figure 1: Andersen Behavioral Model 






RM Andersen. Revisiting the behavioral model and access to medical care: does it matter? J 
Health Social Behavior 1995; 36:1-10 
METHODS  
Study Design 
We used a retrospective, observational, cohort study design. For the purposes of this 
study we used the Medicare 5% sample claims database for years 2006-2007. 
Data Source: Medicare Five-Percent Sample Claims Database 
The Medicare 5% sample claims database contains all final action claims data for a 
random five percent sample of all claims of Medicare beneficiaries 
(http://aspe.hhs.gov/datacncl/datadir/cms.htm). Available standard analytic files (SAF) in 
Medicare 5% sample claims database are: (1) inpatient, (2) outpatient (encompassing claims 
from physician office), (3) skilled nursing facility, (4) carrier, (5) hospice care, (6) home health, 
and (7) durable medical equipment analytic data files. The Medicare 5% sample claims database 
can be used to conduct both cross-sectional and longitudinal studies. A unique, de-identified 
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longitudinally. Several studies have been conducted using this database (Bozic et al., 2012; 
Bozic et al., 2013; Escarce & McGuire, 2003). The information recorded in the claims dataset 
include dates of service provided, charge and payment amounts, clinical diagnosis codes, as well 
as procedure codes. Information on demographic characteristics such as age, gender, and 
race/ethnicity are available in the denominator files of Medicare claims dataset.  
The SAF for home healthcare consist of fee-for-service claims for Medicare-certified 
services, service dates, claim payment amount, primary diagnosis code (ICD-9-CM codes), up to 
9 other diagnosis codes, and total number of home healthcare visits. In the home healthcare SAF, 
the service begin and end dates does not necessarily reflect dates of services and some of the 
detailed information on types of care received by Medicare beneficiaries are available in revenue 
center files.  
Study Population: 
Our study population comprised of community-dwelling elderly Medicare beneficiaries 
aged 65 years and older. Additionally, we required that the elderly Medicare beneficiaries have 
continuous Medicare Part A and B enrollment for 2006 and 2007. Medicare individuals enrolled 
in Health Maintenance Organizations (HMO) were excluded due to unavailability of HMO 
claims in the Medicare 5% sample database. Individuals with PD were identified using 
International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) 
codes of 332.xx in calendar year 2006.  Previous literature has shown that identifying PD 
individuals with ICD-9-CM codes from Medicare database to be reliable with modest sensitivity 
(61.13%) and positive predictive value (65.13%), and the very high specificity (99.08%) when 
all standard analytic files were used (Noyes, Liu, Holloway, & Dick, 2007). To be included in 
the final study sample, individuals with and without PD were required to have positive direct 
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healthcare expenditures. Individuals with end-stage renal disease (ESRD) as well as those 




Home healthcare Use 
 Home healthcare visits were identified from the home healthcare SAF.  Elderly Medicare 
beneficiaries with any home healthcare visit during 2007 were considered to be home health 
users. 
Healthcare Expenditures 
Among users of home healthcare, we examined home healthcare expenditures. We used 
actual Medicare payments to estimate home healthcare expenditures from home healthcare file. 
Expenditure data are generally skewed to the right. Therefore, we transformed expenditures with 
natural logarithm.  
Key Independent Variable: PD and no PD 
Presence or absence of PD constituted the key independent variable for this study. 
Presence of PD was ascertained by using ICD-9-CM codes of 332.xx during 2006 calendar year. 
Other Independent Variables 
The predisposing characteristics comprised of gender (male/female), race/ethnicity 
(white, African American, Latino and other), and age (65-74; and 75 years and older). Enabling 
characteristics will consist of public assistance (which was indicated by Medicare premiums and 
deductibles that were subsidized by the state keeping in view the financial status of the enrollee). 
The need factors constituted of co-occurring chronic conditions. Healthcare behavior consisted 
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of substance use disorders that included alcohol, tobacco and drug use. This domain also 
included baseline healthcare use. The external environment factors comprised of census region 
and metro status. 
Statistical Methods 
 Statistically significant differences in home healthcare use in 2007 by presence of PD 
were ascertained with chi-square tests. We used logistic regressions to examine the association 
between home healthcare use and PD after controlling for predisposing, enabling, need factors, 
personal health behaviors and external environment. 
 We examined the differences in average home healthcare expenditures between PD and 
no PD groups by using t-tests. We also conducted Ordinary Least Square (OLS) regressions on 
logged home healthcare expenditures in 2007 adjusting for all the independent variables to 
examine the relationship between PD and home healthcare expenditures.  
Post-Regression Linear Decomposition of Home Healthcare Expenditures  
  The Blinder and Oaxaca decomposition technique has been used for several decades 
after it was initially developed to explain wage differentials between men and women (Oaxaca, 
1973). Blinder-Oaxaca decomposition technique can be expressed with the following sets of 
equations: 
Yi = β0i + Σ
n
j=1Xiꞌβi + €i 
Where Yi represents the dependent variable (in this case logged home healthcare 
expenditures) for i
th
 individual who may or may not have PD; Xꞌ represents the vector of 
independent variables such predisposing, enabling, need, personal health behavior and external 
environment factors which may be associated with home healthcare expenditures; βi is the 
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parameter vector and €i is the error term which follows a standard normal distribution (0, σ€); and 
β0i is the estimated intercept.  
 According to the Blinder-Oaxaca decomposition technique, the difference in log-
transformed home healthcare expenditures among individuals with and without PD can be 
expressed as follows: 
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Where the intercepts of the OLS regressions among individuals with and without PD are 
represented respectively as
NPDPDand 00
ˆˆ  ; the estimated jth coefficient of the OLS regression 
among individuals with and without PD are represented as PD
jˆ and 
NPD
jˆ  respectively; and the 
average distribution of the jth measured characteristics among individuals with and without PD 
are represented by PD
jX  and 
NPD
jX respectively. The estimated differences in expenditures can 
be divided further into two components: explained and unexplained differences. 








ˆˆ)ˆˆ()(ˆ      
(Explained portion)   (Unexplained portion)  
The explained portion of the gap is the sum of the differences between individuals with 
and without PD in terms of the observed or measured characteristics weighted by the estimated 
coefficients of individuals with PD. The unexplained portion of the gap represents the sum of the 
differences of the estimated coefficients between individuals with and without PD weighted by 
the estimated coefficient of individuals without PD. There is an „index-number‟ problem that 
exists in this approach which arises based on the group which is taken as reference. As for 
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instance, the estimated explained and unexplained gaps might differ depending on whether 
individuals with PD or without PD are taken as the reference. One possible solution to this 
problem suggested by Neumark (1988) is to use the regression estimates from pooled 
regressions. The equation for Neumark‟s decomposition using the pooled regression coefficient 
is as follows: 
















ˆˆ)ˆˆ()(ˆ      
(Explained portion using  (Unexplained portion using pooled 
regression pooled regression coefficient)    coefficient) 
 
 According to the Neumark‟s decomposition using the pooled regression coefficient, the 
explained portion of the gap is the sum of the differences between individuals with and without 
PD in terms of the observed or measured characteristics weighted by the estimated pooled 
coefficients of the regression. The unexplained portion of the gap in this case represents the sum 
of the differences of the estimated coefficients between individuals with and without PD 
weighted by the estimated pooled coefficient of regression. In this study we report estimates 
from pooled, individuals with PD, and individuals without PD regressions to differentiate 
between the explained and unexplained portion of the home healthcare costs among individuals 
with and without PD (Neumark 1988).  
Post-Regression Non-Linear Decomposition of Home Healthcare Use  
To assess the extent to which differences in home healthcare use among individuals with 
and without PD can be explained by predisposing, enabling, need factors, personal health 
behaviors and external environment we used a post-regression non-linear decomposition 
technique. The differences in home healthcare use between the two groups of elderly individuals 
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with and without PD are compartmentalized into two parts: 1) one part is attributable to the 
differences in characteristics, which is the explained portion of the differences and 2) the other 
part is the differences attributable to differences in coefficients. The contribution of each of the 
individual-level factors to the gap in terms of home healthcare use between the two groups is 
estimated by the change in the mean predicted probability by superimposing the distribution of 
elderly Medicare beneficiaries with PD to those without PD, keeping all other factors constant 
(Fairlie, 2003). Some of the common problems associated with the non-linear decomposition 
techniques include the “index number” problem and path dependency. The multivariate 
technique developed by Powers et al. 2011overcomes the “index number” problem by using 
pooled coefficients. Moreover, the mvdcmp technique of Powers et al. 2011, uses an algorithm 
that helps in transforming the estimates from the general regression equation using an ANOVA-
type or centered-effects restriction into normalized equation. This helps in overcoming the bias 
due to reference groups.  
All analyses were conducted using SAS version 9.3 (SAS Institute Inc., Cary, NC) and 
STATA version 13.0. Microsoft Excel 2010 was used to perform the Blinder-Oaxaca linear 
decomposition and multivariate non-linear decomposition.  
RESULTS 
 Table 1 displays the description of the study sample.  The study sample consisted of 
10,865 elderly Medicare beneficiaries with PD and 997,785 elderly Medicare beneficiaries 
without PD. In terms of predisposing, enabling, personal health behavior, need and external 
environmental factors, all the characteristics were statistically significantly different between 
elderly Medicare beneficiaries with and without PD except for baseline substance use disorder 
and cancer.   
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Predisposing characteristics: Among elderly Medicare beneficiaries with PD, a higher 
percentage were men (50.1%) and among those without PD a significantly lower percentage 
were men (39.8%). A greater proportion of elderly Medicare beneficiaries with PD were 75 years 
and older (63.9%) and a lower proportion of elderly Medicare beneficiaries without PD were 75 
years and older (48.5%). The study sample consisted of an overwhelming majority of whites in 
both the groups (around 90% in both groups).  
Enabling characteristics:  A higher percentage of elderly Medicare beneficiaries were on public 
assistance among those with PD (16.0%) compared to those without PD (11.4%).  
Need characteristics: Significantly higher proportion of elderly Medicare beneficiaries with PD 
had mental health conditions such as anxiety (10.9% vs 5.9%) and depression (23.6% vs. 8.8%) 
compared to those without PD. In terms of the physical health conditions, elderly Medicare 
beneficiaries with PD compared to those without PD had a higher proportion of arthritis (33.9% 
vs. 29.5%), Chronic Obstructive Pulmonary Disorders (COPD) (18.0% vs. 16.6%), Chronic 
Renal Failure (CRF) (8.4% vs 5.9%), Chronic Renal Problems (CRP) (8.8% vs. 6.5%), heart 
disease (62.5% vs. 51.9%), stroke (17.0% vs. 6.9%), and thyroid disorder (26.1% vs. 22.5%).  
Healthcare Behavior: Elderly Medicare beneficiaries with PD had significantly higher rates of 
baseline inpatient, outpatient, hospice, skilled nursing facilities, and durable medical equipment 
use.  
External Environment: An overwhelmingly higher percentage of elderly Medicare beneficiaries 
resided in the metro regions in both the two groups (approximately 80% in both groups). Elderly 
Medicare beneficiaries in both PD and no PD groups resided primarily in the Southern census 
region (around 38% in both groups) followed by Mid-West, North-East and Western regions. 
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Table 2 exhibits the relationship between predisposing, enabling, personal health 
behavior, need and external environmental factors and home healthcare use by PD status.  For 
convenience of reading, we only present those with home healthcare use by PD status. There 
were 2,445 and 91,971 elderly Medicare beneficiaries with and without PD respectively who had 
positive home healthcare use. It was observed that for predisposing, enabling, need, personal 
health behavior and external environmental factors, the home healthcare use was statistically 
significantly higher among elderly Medicare beneficiaries with PD compared to those without 
PD.  
Table 3 summarizes the findings from the logistic regression analyses of home healthcare 
use in the study sample. It was observed that after controlling for predisposing, enabling, need, 
personal health behavior, and external environmental factors, elderly individuals with PD were 
greater than two times (Adjusted Odds Ratio: 2.07; 95% Confidence Interval- 1.97-2.17) more 
likely to have home healthcare use compared to those without PD. 
 Table 4 provides the average total and home healthcare of expenditures among those with 
home healthcare use. The average total expenditures among elderly Medicare beneficiaries (who 
used home healthcare service) with PD ($31,154) was significantly higher compared to those 
without PD ($29,465). The average home healthcare expenditures among elderly Medicare 
beneficiaries (who used home healthcare service) with PD was 1.34 times higher compared to 
those without PD ($6,792 vs. $5,060).  
 Table 5 presents the results from the OLS regressions on log-transformed home 
healthcare expenditures among elderly individuals with and without PD, who had a positive 
home healthcare expenditure. Table 5 also provides results from OLS regression on a pooled 
sample which included both elderly Medicare beneficiaries with and without PD. The bottom 
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panel of Table 5 provides the parameters estimates of the key independent variable of this study 
(presence or absence of PD). It can be noted from this part that elderly Medicare beneficiaries 
with PD had approximately 37% (calculated using the formula exp
(β)
 - 1) higher home healthcare 
expenditure compared to those without PD.   
 Table 6 shows the results from the non-linear decomposition on the home healthcare use 
(yes/no). Elderly Medicare beneficiaries with PD had higher home healthcare use compared to 
those without PD (22.50% vs. 9.22%). This translated into a 13.28 percentage point difference 
between these two groups in terms of home healthcare use. From the multivariate decomposition 
analysis, it was observed that out of the 13.28 percentage point difference in home healthcare use 
among elderly Medicare beneficiaries, 3.54 percentage point difference was explained by the 
individual level variables included in this study. Thus, approximately 27% difference in home 
healthcare use among elderly Medicare beneficiaries with and without PD was explained by the 
predisposing, need, personal health choice and external environmental factors. Need 
characteristics (physical and mental health conditions) and personal health behaviors (baseline 
resource use) of the elderly Medicare beneficiaries explained the highest (approximately 80%) 
proportion of the home healthcare use differences between elderly Medicare beneficiaries with 
and without PD. 
 Table 7 displays the results of linear decomposition of home healthcare expenditures 
among elderly Medicare beneficiaries with and without PD. These analyses were restricted to 
only those who used home healthcare. The mean log-transformed home healthcare expenditures 
among elderly Medicare beneficiaries with and without PD was 8.44 and 8.10 units respectively. 
This translated into a 0.34 unit difference in mean log-transformed home healthcare 
expenditures. Using PD, No PD and pooled weights, the explained portion of the home 
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healthcare expenditure differences among elderly Medicare beneficiaries with and without PD 
ranged from 10.8%, 7.8% and 7.7% respectively. The remaining majority of the home healthcare 
expenditure differences remained unexplained. It was observed that baseline resource use 
explained the highest proportion of the home healthcare expenditure differences followed by the 
mental health conditions (anxiety and depression). Using the pooled weights, it can be inferred 
that ceteris paribus, if the baseline resource use was similar between elderly Medicare 
beneficiaries with and without PD, then the log-transformed home healthcare expenditure would 
decrease by 0.1 units. The negative coefficient of the predisposing characteristics signifies that if 
the gender, race/ethnicity and age characteristics of elderly Medicare beneficiaries with and 
without PD were similar, then the difference in log-transformed home healthcare expenditures 
would increase by 0.06 units.  
DISCUSSION 
 The present study examined the magnitude of the difference in home healthcare resource 
use and expenditures among elderly Medicare beneficiaries with and without PD. This study also 
evaluated the extent to which predisposing, enabling, need, personal health behaviors and 
external environmental factors explained the differences among elderly Medicare beneficiaries 
with and without PD. It was observed that after adjusting for the predisposing, need, personal 
health choice and external environmental factors, elderly Medicare beneficiaries with PD had 
13.28% and 37% higher home healthcare use and expenditures respectively compared to those 
without PD. Previous studies have consistently pointed that home healthcare use and 
expenditures among individuals with PD are significantly higher among individuals with PD 
((Bhattacharjee & Sambamoorthi, 2013; Noyes et al., 2006; Pressley et al., 2003; Rubenstein, 
Chrischilles, & Voelker, 1997)). However, no study examined the factors associated with higher 
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home healthcare use and expenditures among elderly individuals with PD and to what extent the 
individual-level factors explain the differences. The unique contribution of this study is to 
provide the factors associated with higher home healthcare resource use and expenditures among 
elderly Medicare beneficiaries with PD and provide a quantified assessment of the extent to 
which these individual-level factors explain the use and expenditures differences using a 
nationally representative sample of Medicare beneficiaries. 
 In terms of resource use, approximately 27% of the 13.28 percentage point differences in 
home healthcare use among elderly Medicare beneficiaries were explained by the individual-
level factors adjusted in this study. The remaining 73% unexplained portion can be due to several 
factors such as severity and duration of PD, medication adherence and inclination towards 
seeking health care. Findings from this study suggest that the need characteristics such as 
baseline comorbidities and personal health behavior characteristics such as resource use (apart 
from home healthcare) explained the highest proportion of the explained differences. These 
findings underscore the importance of developing interventions such as development of 
appropriate evidence based co-management of multiple chronic conditions. Moreover, these 
findings also suggest that there is a need of collaborative care among different specialists such as 
neurologists, endocrinologists, mental health specialists to provide a complete and holistic care 
to these elderly individuals with chronic diseases. Integrated Delivery Systems (IDS) where 
primary physicians serve as the gate-keeper and maintain a good referral system can also be 
helpful in treating elderly individuals with multiple chronic conditions. In the light of recent 
Affordable Care Act (ACA), there is an emphasis on team-based approaches such Patient 
Centered Medical Home (PCMH) where continuous and well-coordinated care is provided by a 
team of healthcare providers 
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(http://www.acponline.org/advocacy/state_health_policy/hottopics/pcmh.pdf). The aims of these 
PCMHs are to provide evidence based treatments for acute and chronic conditions, as well as 
providing preventive services. These types of care models may improve health outcomes of 
elderly individuals and hence has the potential to reduce service use and expenditures.  
In terms of the home healthcare expenditures among elderly Medicare beneficiaries 
having positive home healthcare use, it was observed that only 11% of the differences in home 
healthcare were explained by the individual-level factors adjusted in this study. One of the major 
reasons of the high unexplained portion may be due to absence of certain variables such as 
activities of daily living (ADL), instrumental activities of daily living (IADL), mental and 
physical health status. Elderly individuals with PD require high assistance with their daily 
activities. Moreover, as the disease progresses, individuals with PD experience higher 
impairment in their mental and physical health status, which in turn leads to compromised 
quality of life. In a study by Noyes et al. (2006) among Medicare beneficiaries it was observed 
that elderly Medicare beneficiaries with PD had significantly higher limitations of ADLs 
(average of 2.9 ADLs for individuals with PD vs. 0.8 ADL for individuals without PD) 
compared to those without PD that may be attributed to the higher home healthcare use and 
expenditures. Due to the limitation of the dataset, this important variable was not adjusted which 
may be attributed to the higher unexplained portion.  
One of the notable findings from this study is that the mental health conditions, 
particularly depression contributed a significant proportion of the explained portion of both home 
healthcare use and expenditures. This finding is consistent with a recent study among 
community-dwelling elderly individuals with PD, which found that mental health conditions 
such as depression and anxiety are the major drivers of higher home healthcare expenditures 
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(Bhattacharjee & Sambamoorthi). It has been well documented in the existing literature that 
mental health conditions such as depression often leads to psychosocial disabilities as well as 
ADL impairment among individuals with PD, which in turn may lead to excess negative health 
outcomes (Oluwadamilola et al. 2012). The prevalence of depression in our study sample was 
approximately 3 times higher among elderly Medicare beneficiaries with PD compared to those 
without PD. Given this high prevalence of depression in the study sample and the associated 
negative health outcomes, it is possible that co-occurring depression may lead to higher home 
healthcare use and expenditures. Moreover, it is noted that overall, need and personal health 
behavior factors explained the biggest proportion of the explained portions in both use and 
expenditures.  
 The study strengths are large sample size, representative sample, and comprehensive list 
of variables. While interpreting the findings, the following limitations need to be noted. 
Prescription drug expenditures information was not available. The findings from this study are 
not generalizable to other populations or setting. Fee-for-service, HMO enrollees are excluded 
from the study sample. Users of home healthcare may be different from non-users of home 
health care in unobserved variables. Our study does not control for such selection bias. Five 
percent Medicare sample will not include many variables that are associated with home 
healthcare use. This may lead to underestimation of the explained portion of the estimated 
differences in home healthcare expenditures among individuals with and without PD. However, 
by using a representative sample of Medicare beneficiaries with linked Medicare claims, we can 
estimate the extent to which unmeasured factors can underestimate explained portion of the 
differences in expenditures among individuals with and without PD.  
 




 Notwithstanding the limitations, this study examined the magnitude of the difference in 
home healthcare resource use and expenditures among elderly Medicare beneficiaries with and 
without PD and also evaluated the extent to which predisposing, enabling, need, personal health 
choice and external environmental factors explained these differences. Elderly individuals with 
PD had 13.28% and 37% higher home healthcare use and expenditures compared to those 
without PD. Individual-level factors used in this study explained 28% and 10% of the differences 
in home healthcare use and expenditures respectively. Future studies should include some of the 
factors such as ADL, IADL, and physical and mental health status to understand their influence 
on the home healthcare use and expenditures among individuals with PD. 
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Table 1: Description of Study Sample by Parkinson’s disease Status  
National Medicare 5% Sample - 2006, 2007 
Variables PD Col % No PD Col % Sig 
  
N = 10,865 
 




    
*** 
 
Female            5,421  49.9          600,932  60.2 
 
 
Male            5,444  50.1          396,853  39.8 
 
Race/Ethnicity 
    
*** 
 
White          10,007  92.1          891,280  89.3 
 
 
AA               425  3.9            65,266  6.5 
 
 
Other               433  4.0            41,239  4.1 
 
Age Group 
    
*** 
 
65-74            3,927  36.1          514,211  51.5 
 
 




   
*** 
 
Yes            1,742  16.0          113,528  11.4 
 
 
No            9,123  84.0          884,257  88.6 
 
External Environmental characteristics 
Census region 
    
*** 
 
North-East            2,399  22.1          192,983  19.3 
 
 
Midwest            2,837  26.1          258,335  25.9 
 
 
South            3,931  36.2          386,457  38.7 
 
 
West            1,698  15.6          160,010  16.0 
 
Metro status 
    
*** 
 
Metro            8,448  77.8          752,534  75.4 
 
 
Non-Metro            2,417  22.2          245,251  24.6 
 
Personal Health Behavior 
 Substance Use  
     
 
Yes               440  4.0            38,529  3.9 
 
 
No          10,425  96.0          959,256  96.1 
 
Inpatient visit 
    
*** 
 
Yes            3,584  33.0          185,807  18.6 
 
 
No            7,281  67.0          811,978  81.4 
 
DME visit 
    
*** 
 
Yes            4,679  43.1          292,847  29.3 
 
 
No            6,186  56.9          704,938  70.7 
 
Hospice visit 
    
*** 
 
Yes               122  1.1              2,746  0.3 
 
 
No          10,743  98.9          995,039  99.7 
 
SNF visit 
    
*** 
 
Yes            1,597  14.7            39,780  4.0 
 
 
No            9,268  85.3          958,005  96.0 
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Table 1: Description of Study Sample by Parkinson’s disease Status  
National Medicare 5% Sample - 2006, 2007 
Variables PD Col % No PD Col % Sig 
  
N = 10,865 
 
N = 997,785 
  
Office visit quintile 
   
*** 
 
0 – 5               502  4.6          178,497  17.9 
 
 
6 – 10            1,335  12.3          225,007  22.6 
 
 
11 – 16            2,082  19.2          211,344  21.2 
 
 
17 – 25            2,632  24.2          188,127  18.9 
 
 
26 – 281            4,314  39.7          194,810  19.5 
 
Outpatient visit quintile 
   
*** 
 
0 – 0            1,708  15.7          251,723  25.2 
 
 
1-2            1,469  13.5          173,905  17.4 
 
 
2 – 3            2,306  21.2          220,167  22.1 
 
 
4 – 6            2,234  20.6          168,324  16.9 
 
 
7 – 178            3,148  29.0          183,666  18.4 
 
       
Need factors 
Anxiety 
    
*** 
 
Yes            1,189  10.9            58,738  5.9 
 
 
No            9,676  89.1          939,047  94.1 
 
Arthritis 
    
*** 
 
Yes            3,679  33.9          294,580  29.5 
 
 
No            7,186  66.1          703,205  70.5 
 
Cancer 
     
 
Yes            1,050  9.7            96,972  9.7 
 
 
No            9,815  90.3          900,813  90.3 
 
COPD 
    
*** 
 
Yes            1,957  18.0          165,673  16.6 
 
 
No            8,908  82.0          832,112  83.4 
 
CRF 
    
*** 
 
Yes               909  8.4            59,362  5.9 
 
 
No            9,956  91.6          938,423  94.1 
 
CRP 
    
*** 
 
Yes               951  8.8            64,633  6.5 
 
 
No            9,914  91.2          933,152  93.5 
 
Diabetes 
    
* 
 
Yes            2,794  25.7          265,381  26.6 
 
 
No            8,071  74.3          732,404  73.4 
 
Heart Disease 
    
*** 
 
Yes            6,787  62.5          518,023  51.9 
 
 
No            4,078  37.5          479,762  48.1 
 
Hypertension 
    
** 
 
Yes            7,743  71.3          723,969  72.6 
 
 
No            3,122  28.7          273,816  27.4 
 
 (Contd.)      
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Table 1: Description of Study Sample by Parkinson’s disease Status  
National Medicare 5% Sample - 2006, 2007 
Variables PD Col % No PD Col % Sig 
  
N = 10,865 
 
N = 997,785 
  
Major Depression 
   
*** 
 
Yes            2,568  23.6            87,822  8.8 
 
 
No            8,297  76.4          909,963  91.2 
 
       
Stroke 
    
*** 
 
Yes            1,849  17.0            68,577  6.9 
 
 
No            9,016  83.0          929,208  93.1 
 
Thyroid disorders 
   
*** 
 
Yes            2,837  26.1          224,754  22.5 
 
 
No            8,028  73.9          773,031  77.5 
 
Note: Based on 10,865 and 997,785 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson‟s 
Disease who were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled 
in Health Maintenance organizations during 2006 and 2007;  had a positive direct total healthcare expenditures; 
Individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some 
other reason were excluded from the final sample. 
 
PD: Parkinson‟s disease; SUD: Substance Use Disorder; COPD: Chronic Obstructive Pulmonary Disorder; CRF: 
Chronic Renal Failure; CRP: Chronic Renal Problem; DME: Durable Medical Equipment; HHA: Home Health 
Agency; SNF: Skilled Nursing Facility 
*** p < .001;  **.001 ≤ p < .01; *  .01 ≤ p < .05 
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Table 2: Number and Percent with Home Healthcare Use by Parkinson's disease 
National Medicare 5% Sample, 2006-2007 
  
PD % with HHA No PD % with HHA Sig 
 
All 2,445 22.5 9,1971 9.2 *** 
  
PD Col % No PD Col % 
 Predisposing characteristics 
Gender 
     
 
Female 1,348 24.9 62,687 10.4 *** 
 
Male 1,097 20.2 29,284 7.4 *** 
Race/Ethnicity 
     
 
White 2,202 22.0 78,889 8.9 *** 
 
African Americans 135 31.8 8731 13.4 *** 
 
Other 108 24.9 4351 10.6 *** 
Age Group 
     
 
65-74 679 17.3 28,962 5.6 *** 
 
75, + 1,766 25.5 63,009 13.0 *** 
Enabling characteristics 
Public Assistance 
    
 
Yes 392 22.5 17,576 15.5 *** 
 
No 2,053 22.5 74,395 8.4 *** 
External Environmental characteristics 
Census region 
     
 
North-East 562 23.4 19,581 10.1 *** 
 
Midwest 529 18.6 20,225 7.8 *** 
 
South 1,031 26.2 40,320 10.4 *** 
 
West 323 19.0 11,845 7.4 *** 
Metro status 
     
 
Metro 1,986 23.5 72,296 9.6 *** 
 
Non-Metro 459 19.0 19,675 8.0 *** 
Personal Health Behaviors 
SUD       
 
Yes 126 28.6 5,580 14.5 *** 
 
No 2,319 22.2 86,391 9.0 *** 
Outpatient Visits Quintile 
   
 
0 – 0 313 18.3 16,557 6.6 *** 
 
1-1 303 20.6 13,330 7.7 *** 
 
2 – 3 514 22.3 19,008 8.6 *** 
 
4 – 6 545 24.4 17,200 10.2 *** 
 
7 - 178 770 24.5 25,876 14.1 *** 
Office visit quintile 
    
 
0 – 5 72 14.3 8,163 4.6 *** 
 
6 - 10 206 15.4 12,666 5.6 *** 
 
11 - 16 372 17.9 16,418 7.8 *** 
 
17 - 25 570 21.7 20,086 10.7 *** 
 
26 - 281 1,225 28.4 34,638 17.8 *** 
 (Contd.)      
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Table 2: Number and Percent with Home Healthcare Use by Parkinson's disease 
National Medicare 5% Sample, 2006-2007 
  
PD % with HHA No PD % with HHA Sig 
 
All 2,445 22.5 9,1971 9.2 *** 
  
PD Col % No PD Col % 
 Need factors 
Anxiety 
     
 
Yes 334 28.1 8,594 14.6 *** 
 
No 2,111 21.8 83,377 8.9 *** 
Arthritis 
     
 
Yes 1,024 27.8 41,726 14.2 *** 
 
No 1,421 19.8 50,245 7.1 *** 
Cancer 
     
 
Yes 278 26.5 11,475 11.8 *** 
 
No 2,167 22.1 80,496 8.9 *** 
COPD 
     
 
Yes 569 29.1 25,518 15.4 *** 
 
No 1,876 21.1 66,453 8.0 *** 
CRF 
     
 
Yes 270 29.7 11,376 19.2 *** 
 
No 2,175 21.8 80,595 8.6 *** 
CRP 
     
 
Yes 293 30.8 11,462 17.7 *** 
 
No 2,152 21.7 80,509 8.6 *** 
Diabetes 
     
 
Yes 725 25.9 33,506 12.6 *** 
 
No 1,720 21.3 58,465 8.0 *** 
Diabetic Nephropathy 
    
 
Yes 41 30.4 2,232 19.6 ** 
 
No 2,404 22.4 89,739 9.1 *** 
Heart disease 
     
 
Yes 1,714 25.3 64,601 12.5 *** 
 
No 731 17.9 27370 5.7 *** 
Hypertension 
     
 
Yes 1,892 24.4 76,422 10.6 *** 
 
No 553 17.7 15,549 5.7 *** 
Depression 
     
 
Yes 684 26.6 14,613 16.6 *** 
 
No 1,761 21.2 77,358 8.5 *** 
Stroke 
     
 
Yes 538 29.1 13,148 19.2 *** 
 
No 1,907 21.2 78,823 8.5 *** 
Thyroid disorder 
    
 
Yes 736 25.9 25,900 11.5 *** 
 
No 1,709 21.3 66,071 8.5 *** 
       
Note: Based on 2,445 and 91,971 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson‟s 
disease who were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled 
in Health Maintenance organizations during 2006 and 2007; had a positive direct total healthcare expenditures; 
Individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some 
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other reason were excluded from the final sample. For ease of reading, percentage without home healthcare use by 
Parkinson‟s disease status is not presented.    
 
Asterisks represent significant group differences by Parkinson‟s disease status based on chi-square tests.  
 
SUD: Substance Use Disorder; COPD: Chronic Obstructive Pulmonary Disorder; CRF: Chronic Renal Failure; 
CRP: Chronic Renal Problem; DME: Durable Medical Equipment; HHA: Home Health Agency; SNF: Skilled 
Nursing Facility 
 
*** p < .001;  **.001 ≤ p < .01; *  .01 ≤ p < .05 
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Table 3: Adjusted Odds Ratios and 95% Confidence Intervals 
from Logistic Regression on Home Healthcare Use  
National Medicare 5% sample, 2006-2007 
  
AOR 95% CI Sig 
Parkinson's disease 
   
 
Yes 2.07 [1.97,2.17] *** 
 
No 
   Predisposing characteristics 
Gender 
   
 
Female 1.30 [1.28,1.32] *** 
 
Male 
   Race/Ethnicity 
   
 
White 
   
 
African American 1.35 [1.31,1.38] *** 
 
Others 1.04 [1.00,1.08] * 
Age Group 
   
 
75, + 2.21 [2.18,2.25] *** 
 
65-74 
   Enabling characteristics 
Public Assistance 
   
 
Yes 1.34 [1.31,1.36] *** 
 
No 
   External Environmental characteristics 
Census 
Region     
 
North-East  1.28 [1.25,1.31] *** 
 
Midwest  1.04 [1.02,1.07] *** 
 
South 1.42 [1.39,1.45] *** 
 
West 
   Metro status 
   
 
Metro 1.20 [1.18,1.22] *** 
 
Non-metro 
   Personal Health Behavior 
SUD 
    
 
Yes 1.19 [1.15,1.23] *** 
 
No 
   Outpatient visit quintile 
   
 
0 – 0 0.93 [0.91,0.95] *** 
 
1-1 0.94 [0.92,0.97] *** 
 
2 - 3 0.94 [0.92,0.96] *** 
 
4 - 6 0.96 [0.94,0.98] *** 
 
7 - 178 
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Table 3: Adjusted Odds Ratios and 95% Confidence Intervals 
from Logistic Regression on Home Healthcare Use  
National Medicare 5% sample, 2006-2007 
  
AOR 95% CI Sig 
Office visit quintile 
   
 
0 - 5 0.70 [0.68,0.72] *** 
 
6 - 10 0.68 [0.67,0.70] *** 
 
11 - 16 0.77 [0.75,0.79] *** 
 
17 - 25 0.86 [0.84,0.88] *** 
 
26 - 281 
   SNF visits 0.95 [0.94,0.96] *** 
Inpatient visits 1.31 [1.30,1.32] *** 
Hospice visits 0.98 [0.97,0.99] *** 
DME visits 1.05 [1.05,1.05] *** 
Need characteristics 
Anxiety 
   
 
Yes 1.04 [1.01,1.07] ** 
 
No 
   Arthritis 
   
 
Yes 1.50 [1.48,1.53] *** 
 
No 
   Cancer 
   
 
Yes 1.03 [1.01,1.06] ** 
 
No 
   COPD 
   
 
Yes 1.13 [1.11,1.15] *** 
 
No 
   CRF 
    
 
Yes 1.17 [1.14,1.20] *** 
 
No 
   CRP 
    
 
Yes 1.11 [1.08,1.14] *** 
 
No 
   Diabetes 
   
 
Yes 1.17 [1.15,1.19] *** 
 
No 
   Diabetic Nephropathy 
   
 
Yes 1.13 [1.07,1.19] *** 
 
No 
   
 
 (Contd.)    
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Table 3: Adjusted Odds Ratios and 95% Confidence Intervals 
from Logistic Regression on Home Healthcare Use  
National Medicare 5% sample, 2006-2007 
  
AOR 95% CI Sig 
Heart disease 
   
 
Yes 1.29 [1.27,1.31] *** 
 
No 
   Hypertension 
   
 
Yes 1.10 [1.08,1.13] *** 
 
No 
   Depression 
   
 
Yes 1.22 [1.19,1.25] *** 
 
No 
   Stroke 
   
 
Yes 1.32 [1.29,1.35] *** 
 
No 
   Thyroid disorder 
   
 




        
Note: Based on 10,865 and 997,785 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson‟s 
Disease who were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled 
in Health Maintenance organizations during 2006 and 2007;  had a positive direct total healthcare expenditures; 
Individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some 
other reason were excluded from the final sample. 
 
PD: Parkinson‟s disease; AOR: Adjusted Odds Ratio; CI: Confidence Intervals; SUD: Substance Use Disorder; 
COPD: Chronic Obstructive Pulmonary Disorder; CRF: Chronic Renal Failure; CRP: Chronic Renal Problem; 
DME: Durable Medical Equipment; SNF: Skilled Nursing Facility 
 
*** p < .001;  **.001 ≤ p < .01; *  .01 ≤ p < .05 
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Table 4: Average Total and Home Healthcare Expenditures among Home Healthcare 
Users 
Elderly Individuals with and without PD 
National Medicare 5% sample, 2006,2007 
 
PD 
N = 2,445 
No PD 
N = 91,971 
 
 
Average Std. Dev Average Std. Dev 
Total** 
           
31,154  
           
27,249  
           
29,465  
           
27,107  
HHA*** 
             
6,792  
             
6,640  
             
5,060  
             
5,849  
% spent on Home Healthcare 21.8% 
 
17.2% 
 Note: Based on 2,445 and 91,971 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson‟s 
disease who were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled 
in Health Maintenance organizations during 2006 and 2007; had a positive direct home healthcare expenditures; 
Individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some 
other reason were excluded from the final sample. For ease of reading, percentage without home healthcare use by 
Parkinson‟s disease status is not presented. 
 
Group differences determined using t-test 
 
*** p < .001;  **.001 ≤ p < .01;  
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Table 5: Regression Estimates, Standard Errors from Ordinary Least Squares Regression 
on Log-transformed Home Healthcare Expenditures 
National Medicare 5% Sample - 2006, 2007 
  
PD No PD Pooled 
  
Beta S.E. Sig Beta S.E. Sig Beta S.E. Sig 
Intercept 8.082 0.102 *** 7.729 0.018 *** 7.730 0.018 *** 
Predisposing characteristics 
Gender 
         
 
Female 0.076 0.041 
 
0.096 0.007 *** 0.095 0.007 *** 
 
Male 
         
Race/Ethnicity 
         
 
White 
         
 
AA 0.166 0.087 
 
0.241 0.011 *** 0.240 0.011 *** 
 
Other 0.086 0.100 
 
0.166 0.016 *** 0.164 0.016 *** 
Age group 
         
 






-0.164 0.007 *** 
 
 75, + years 
         
Enabling characteristic 
Public assistance 
         
 
Yes 0.110 0.057 
 
0.184 0.009 *** 0.182 0.009 *** 
 
No 
         
External environmental characteristics 
Census region 
         
 






-0.068 0.011 *** 
 






-0.141 0.011 *** 
 
South 0.171 0.062 ** 0.167 0.010 *** 0.168 0.010 *** 
 
West 
         
Metro status 
         
 
Metro 0.095 0.052 
 
0.069 0.008 *** 0.070 0.008 *** 
 
Non-Metro 
         
Need factors- Baseline comorbidities and resource use 
Anxiety 
         
 










         
Arthritis 
         
 
Yes 0.063 0.041 
 
0.094 0.007 *** 0.093 0.007 *** 
 
No 
         
 (Contd.)          
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Table 5: Regression Estimates, Standard Errors from Ordinary Least Squares Regression 
on Log-transformed Home Healthcare Expenditures 
National Medicare 5% Sample - 2006, 2007 
  
PD No PD Pooled 
  
Beta S.E. Sig Beta S.E. Sig Beta S.E. Sig 
Cancer 
         
 






-0.054 0.010 *** 
 
No 
         
COPD 
         
 






-0.040 0.008 *** 
 
No 
         
CRF 
         
 








         
CRP 
         
 








         
Diabetes 
         
 
Yes -0.009 0.045 
 
0.075 0.007 *** 0.072 0.007 *** 
 
No 
         
Diabetic Nephropathy 
        
 
Yes 0.299 0.158 
 
0.087 0.022 *** 0.091 0.021 *** 
 
No 
         
Heart disease 
         
 
Yes 0.052 0.048 
 
0.043 0.008 *** 0.043 0.008 *** 
 
No 
         
Hypertension 
         
 








         
Major Depressive Disorder 
        
 
Yes 0.035 0.047 
 
0.095 0.009 *** 0.094 0.009 *** 
 
No 
         
Stroke 
         
 
Yes -0.025 0.049 
 
0.153 0.009 *** 0.146 0.009 *** 
 
No 
         
Thyroid Disorder 
         
 
Yes -0.035 0.044 
 
0.019 0.007 ** 0.018 0.007 * 
 
No 




(Contd.)          
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Table 5: Regression Estimates, Standard Errors from Ordinary Least Squares Regression 
on Log-transformed Home Healthcare Expenditures 
National Medicare 5% Sample - 2006, 2007 
  
PD No PD Pooled 
  
Beta S.E. Sig Beta S.E. Sig Beta S.E. Sig 
Personal Health Choices 
SUD 
         
 






-0.034 0.014 * 
 
No 
         
Outpatient Visit Quintile 
        
 
0 – 0 0.056 0.069 
 
0.053 0.011 *** 0.053 0.010 *** 
 




















-0.027 0.009 ** 
 
7 - 178 
         
Office Visit Quintiles   
        
 





-0.047 0.014 *** 
 






-0.051 0.011 *** 
 






-0.043 0.010 *** 
 






-0.048 0.009 *** 
 
26 - 281 
         
Other Resource Utilizations 
        
 
SNF visits 0.033 0.017 
 
0.061 0.004 *** 0.059 0.004 *** 
 
Inpatient visits 0.082 0.018 *** 0.022 0.003 *** 0.024 0.003 *** 
 
Hospice visits 0.024 0.027 
 
0.027 0.005 *** 0.027 0.005 *** 
 
DME visits 0.015 0.003 *** 0.017 0.000 *** 0.017 0.000 *** 
Pooled regression coefficient for the presence or absence of PD 
Parkinson's Disease 
        
 
Yes 
      
0.313 0.020 *** 
 
No 
         
Note: Based on 2,445 and 91,971 elderly (age 65 or older) Medicare beneficiaries with and without Parkinson‟s 
disease who were continuously enrolled in Medicare Part A and Part B during 2006 and 2007 and were not enrolled 
in Health Maintenance organizations during 2006 and 2007; had a positive direct home healthcare expenditures; 
Individuals with end-stage renal disease (ESRD) as well as those without full year enrollments due to death or some 
other reason were excluded from the final sample. 
SUD: Substance Use Disorder; COPD: Chronic Obstructive Pulmonary Disorder; CRF: Chronic Renal Failure; 
CRP: Chronic Renal Problem; DME: Durable Medical Equipment; SNF: Skilled Nursing Facility 
 
*** p < .001;  **.001 ≤ p < .01; *  .01 ≤ p < .05 
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Table 6: Non-Linear decomposition of baseline home healthcare use 
among elderly 
Medicare beneficiaries with and without PD 
Multivariate Decomposition of Non-Linear dependent variable 
Medicare 5% claims database (2006, 2007) 
Variables  
Weights  





gender, race/ethnicity, age 0.008 
Enabling characteristic 
     Public assistance                                          -0.002 
Need characteristics 
 
Physical health conditions 0.0038 
 
Mental health conditions (anxiety, 
depression) 
0.002 
Personal Health choices 
 
Any type of SUD 0.00002 
 
Baseline resource use 0.0235 
External environment 
 
Census region, metro-status 0.0001 
Total explained 0.0354 
Unexplained portion 0.09746 
Percentage explained 26.64% 
Note: Based on 10,865 and 997,785 elderly (age 65 or older) Medicare beneficiaries with and without PD  
Difference in home healthcare use = 13.28 percentage points. Percentage points in home healthcare use are 
explained by each independent variable. The percentage explained is derived by dividing the total explained portion 
by the 13.28 percentage point difference between elderly Medicare beneficiaries with and without PD. 
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Table 7: Linear decomposition of logged home healthcare expenditures among elderly 
Medicare beneficiaries with and without PD 
Blinder-Oaxaca Linear Decomposition Technique 
Medicare 5% claims database (2006, 2007) 
Variables  
Weights  
(in percentage points) 
  
Pooled PD No PD 
Predisposing characteristics 
 
gender, race/ethnicity, age -0.05 -0.039 -0.048 
Enabling characteristic 
     Public assistance -0.016 -0.009 -0.017 
Need characteristics 
 
Physical health conditions 0.014 0.003 0.013 
 
Mental health conditions (anxiety, depression) 0.032 0.012 0.033 
Personal Health choices 
 
Any type of SUD 0.0009 0.003 0.0008 
 
Baseline resource use 0.105 0.143 0.105 
External environment 
 
Census region, metro-status -0.009 -0.005 -0.009 
Total explained 0.077 0.108 0.078 
Unexplained portion 0.923 0.892 0.922 
Percentage explained 7.7% 10.8% 7.8% 
Note: Based on 2,445 and 91,971 elderly (age 65 or older) Medicare beneficiaries with and without PD who had a 
positive home healthcare expenditures 
lnexp (PD) = 8.44 and lnexp (No PD) = 8.10; total difference = 0.34 
SUD: Substance Use Disorder 
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CHAPTER 3: Parkinson’s disease and Burden on Informal Caregivers: Results from the 
National Alliance of Caregiving Survey 
                        
INTRODUCTION 
 Parkinson‟s disease (PD), the second most common neurodegenerative disease, is 
characterized by motor and non-motor symptoms (Muangpaisan, Mathews, Hori, & Seidel, 
2011). With the progression of PD, the motor (rigidity, postural instability, resting tremors) and 
non-motor (loss of smell, visual hallucinations, sleep disorders) symptoms worsen leading to 
severe disability (Muangpaisan et al., 2011; Park & Stacy, 2009). In addition to motor and non-
motor symptoms, individuals with PD also exhibit cognitive impairment and behavioral issues 
(Lau & Au, 2011). Due to movement difficulties and cognitive decline, individuals with PD 
frequently experience limitations in activities of daily living (ADLs) well as instrumental 
activities of daily living (IADLs) (Cahn et al., 1998; Noyes, Liu, Li, Holloway, & Dick, 2006; 
Whetten-Goldstein, Sloan, Kulas, Cutson, & Schenkman, 1997). It has been estimated that up to 
two-thirds of elderly individuals with PD experience ADL and IADL difficulties (Noyes et al., 
2006; Whetten-Goldstein et al., 1997).  
Parkinson’s disease and Informal Caregivers 
Because of limitations of ADLs, IADLs, motor and non-motor symptoms, cognitive 
impairment and behavioral issues individuals with PD rely on formal and informal caregivers for 
performing their daily activities (Noyes et al., 2006; Whetten-Goldstein et al., 1997). An 
overwhelming majority (as high as 78%) of individuals with PD relied on their caregivers for 
ADL/IADL activities (Noyes et al., 2006; Whetten-Goldstein et al., 1997). As majority of elderly 
individuals with PD live in communities, caregiving is mainly provided by spouse or children of 
individuals with PD (Lau & Au, 2011). A meta-analysis found that majority (86.4%) of the 
caregivers of PD were spouses, and 10.1% of the caregivers were adult children of individuals 
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with PD (Lau & Au, 2011). When caregiving is provided by close family members, relatives, or 
friends who do not have any organizational affiliations or certificates for caregiving they are 
considered as informal caregivers (Rakoski et al., 2012). It has been estimated that in the U.S 
65.7 million adult individuals provide informal caregiving to individuals who are ill, disabled or 
aged [The National Alliance for Caregiving and AARP (2009), Caregiving in the U.S. National 
Alliance for Caregiving. Washington, DC.] and 43.5 million adult caregivers provide care for 
older individuals (age ≥ 50 years). According to the American Time Use Survey in 2011, an 
estimated average of 3.12 hours per day was spent in providing informal care to elderly 
individuals for several different activities such as eating, drinking, managing funds, grocery 
shopping, and other household activities etc. (http://www.bls.gov/news.release/atus.htm).  
Parkinson’s disease and Informal Caregiver Burden 
Although caregiving is a part of life, providing care to individuals with chronic illness, 
functional limitations, and cognitive decline can be burdensome. This is because providing care 
to these individuals can be highly stressful as caregiving involves fear or uncertainty, shift in 
roles, financial burden, social isolation, little time alone, demands of constant care and feel of 
guilt 
(http://www.wfmh.org/PDF/Caring%20for%20the%20Caregiver%2011_04_09%20FINAL%20
%283%29.pdf). Moreover, with the increase in severity of the illness, caregivers have to 
undertake new and increased burdensome responsibilities, which generally lead to elevated 
levels of psychological, emotional, financial and physical burden of caregivers (Sanders-Dewey, 
Mullins, & Chaney, 2001; Whetten-Goldstein et al., 1997).  
In concept, caregiver burden is defined as “the strain or load borne by a person who 
cares for an elderly, chronically ill, or disabled family member or other person. . . . the point 
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where the experience is no longer a viable or healthy option for either the caregiver or the 
person receiving care” (Kasuya, Polgar-Bailey, & Takeuchi, 2000). However, in practice it is 
challenging to precisely measure informal caregiver burden. Caregiver burden is often measured 
by Zarit Burden Inventory, which is a 22-item caregiver-reported scale or a visual analogue scale 
(VAS) known as Caregiver Distress Scale. ZBI measures many aspects of caregiver burden 
including emotional and physical health of the caregivers, financial issues of the caregivers, the 
impact of caregiving on their social life (Seng et al., 2010). Caregiver Distress Scale measures 
caregiver stress on a scale of zero to ten with zero indicating no stress and 10 indicating 
overwhelming stress (Cifu et al., 2006). Simpler measures have been used in the existing 
literature. Some studies have measured the caregiver burden by the number of hours spent on 
caregiving and the costs associated with it (Parrish, Giunta, & Adams, 2003; Rakoski et al., 
2012).  
Informal caregiving is especially burdensome among caregivers of individuals with PD. 
Evidence of this association comes mainly from studies that have been conducted in international 
settings. Studies conducted in different countries (Korea, Denmark, Norway, Ireland, Sweden, 
Spain, Brazil, Australia, Italy, and United Kingdom) have shown that the informal caregiver 
burden of those caring for individuals with PD  was higher as compared to the caregiver burden 
of individuals caring for individuals with other chronic disease conditions (D'Amelio et al., 2009; 
Hounsgaard, Pedersen, & Wagner, 2011; Kim et al., 2007; Lökk, 2009; Lökk, 2009; Martínez-
Martín et al., 2005; O'Connor & McCabe, 2011; O'Reilly, Finnan, Allwright, Smith, & Ben-
Shlomo, 1996; Peters, Fitzpatrick, Doll, Playford, & Jenkinson, 2011; Stella, Banzato, Quagliato, 
Viana, & Christofoletti, 2009; Thommessen et al., 2002). In one study conducted in Korea, it 
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was observed that caregivers of individuals with PD experienced higher burden of caregiving 
compared to other general chronic diseases (Kim et al., 2007).  
Only a handful of studies have evaluated the informal caregiver burden among those 
providing care to individuals with PD in the U.S. (Carter, Stewart, Lyons, & Archbold, 2008; 
Cifu et al., 2006; Edwards & Ruettiger, 2002; Parrish et al., 2003). According to a 1999 study of 
324 informal caregivers of individuals with PD in California area, it was reported that informal 
caregivers provided an estimated average of 96 hours/week, caring for individuals with PD 
(Parrish et al., 2003). In addition, a majority (over 70%) of caregivers suffered ADLs (eating, 
dressing, toileting, transferring), IADLs (taking medication), and other health related issues due 
to caregiving. Informal caregiver burden is also associated with many factors. One study 
conducted among 41 caregivers of individuals with PD in six Midwestern states of U.S. showed 
that greater assistance with ADLs was significantly associated with caregiver burden (Edwards 
& Ruettiger, 2002). Using data from 49 caregivers of individuals with PD from the Parkinson‟s 
disease Research, Education, and Clinical Center (PADRECC) in Richmond, Virginia, U.S., it 
was found that caregiver burden increased when individuals with PD had greater levels of 
difficulty in performing ADLs (Cifu et al., 2006). Another study using data from an 8-year 
clinical trial DATATOP, found that among 219 caregivers of individuals with PD, clinical 
symptoms of PD, depression, motor and non-motor psychological symptoms were associated 
with caregiver burden (Carter et al., 2008). 
Need for the study 
 Although these studies evaluated informal caregiver burden among individuals with PD, 
they are limited by geographical locations within the U.S. (Edwards & Ruettiger, 2002) and 
small sample size (Cifu et al., 2006). Many of these studies are outdated with data from as early 
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as1999 (Parrish et al., 2003). Additionally, none of these studies estimated costs associated with 
informal caregiving among caregivers of individuals with PD. Furthermore, according to the 
Administration on Aging of the Department of Health and Human Services, by 2030 there will 
be an estimated 72.1 million elderly individuals (age ≥ 65 years) as compared to 39.6 million 
elderly individuals in 2009 (http://www.aoa.gov/Aging_Statistics/).  Similarly, the number of 
individuals with PD is expected to rise two-fold by 2030 (Park & Stacy, 2009). This growth in 
the number of individuals with PD has implications for caregiving burden and costs associated 
with informal caregiving. In this context, it is important to identify caregivers who are at high 
risk for high care burden so that programs and interventions can be developed to improve the 
well-being of the caregivers.  
Therefore, the primary objective of the current study was to estimate the extent of 
caregiver burden and costs associated with informal caregiving and examine factors associated 
with such burden among caregivers of individuals with PD. For purposes of the current study, we 
used a nationally representative data from the National Alliance of Caregiving, American 
Association of Retired Persons (NAC/AARP) survey using 2004 and 2009 data.  
Conceptual Framework 
 The conceptual framework used for this study was the Stress-Process Model developed 
by Conde-Sala et al. (2010). According to this frame-work, different factors associated with the 
burden of caregiving are: (i) Contextual variables which encompasses socio-demographic factors 
of both care-recipients and caregivers as well as factors associated with caregiving; (ii) primary 
stressors such as the progression of the disease or symptoms of patients; and (iii) secondary 
stressors which constitutes caregiving related factors which leads to difficulties in different 
settings such as family, work or financial (Conde-Sala et al. 2010). One of the advantages of this 
Page 65 of 129 
 
model is that it utilizes a multidimensional perspective on the factors associated with caregiving 
burden and takes into account both observed and conceptual aspects (Kim et al. 2012). We used 
a modified version of this conceptual model as some of the variables are not available due to 
limitations of the dataset.  
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Highlighted parts were examined in this study 
Model adapted from Conde-sala et al. (2010): Conde-Sala J.L., Garre-Olmo J., Turro-Garriga O., 
Vilalta-Franch J. & Lopez-Pousa S. (2010). Differential features of burden between spouse and 
adult-child caregivers of patients with Alzheimer‟s disease: an exploratory comparative design. 




 We adopted a retrospective cross-sectional study design with observational data.  
Data Source:  National Alliance for Caregiving (NAC)  
 We used multiple years (2004, 2009) of data from the National Alliance for Caregiving, 
American Association of Retired Persons (NAC/AARP) survey. The nationwide survey data 
were collected by NAC/AARP by using a random digit dialing on the basis of surname. For the 
NAC data collected in 2004, 6,139 adults (age ≥ 18 years) residing in the US were interviewed, 
and 6,806 adult individuals within US were interviewed for the data collected in 2009. The 
survey design of NAC included oversampling of minorities to attain a total of 200 African 
American caregivers, 200 Hispanic caregivers, and 200 Asian caregivers (NAC/AARP 2004c; 
NAC/AARP 2009c). The national random digit dialing (RDD) was stratified by geographical 
location in order to obtain a set of telephone numbers that were proportionate to the population 
of that area. The survey consisted of 1,247 and 1,397 caregivers for 2004 and 2009 NAC survey 
data (NAC/AARP 2004a; NAC/AARP 2009a). 
Study Sample 
The study sample consisted of elderly care-recipients aged 65 years or older. The care-
recipients were categorized as individuals with (i) PD and (ii) no PD.  
Individuals who provided help with at least one activity of daily living or instrumental 
activity of daily living were classified as informal Caregivers (Kim et al. 2012). The question in 
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the survey that helped to classify caregivers was “In the last 12 months, has anyone in your 
household provided unpaid care to a relative or friend 50 years or older to help them take care 
of themselves?  Unpaid care may include help with personal needs or household chores. It might 
be managing a person's finances, arranging for outside services, or visiting regularly to see how 
they are doing. This person need not live with you.” Pooling data from 2004 and 2009 NAC 
survey, we had 32 caregivers who provided care to elderly care-recipients with PD and 1,639 
caregivers who provided care to other elderly care-recipients without PD meeting the study 
inclusion criteria. The complex multistage sampling design of NAC survey was adjusted by 
incorporating the survey weights in the SAS survey statistical procedures, such as 
SURVEYFREQ and SURVEYMEANS. The SURVEYREG procedure was used to conduct the 
Ordinary Least Square (OLS) regression analysis by adjusting for complex survey design.  
Data Collection/Field Methodology 
 The nationally representative data was collected via telephone interviews. After 
establishing telephone contact, the interviewer asked to speak to an individual in the household 
who had the most-recent birthday and were 18 years or older. If the initial respondent was not the 
caregiver, then the interviewer requested to speak to the caregiver and only one caregiver from 
each household was interviewed. Household information, demographic information as well as 
other appropriate data on both caregivers and care-recipients was collected in the NAC survey. 
The interview was terminated in the cases where the randomly selected primary respondent 
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Approvals 
 NAC/AARP approved the use of the anonymous and de-identified survey data. The 
Institutional Review Board (IRB) of West Virginia University approved this study before the 
initiating the data analysis. 
Dependent Variables 
Caregiver burden 
 Caregiver burden was measured based on three questions on physical strain (“How much 
of a physical strain caring for recipient is/was for you?”), emotional stress (“How emotionally 
stressful caring for recipient is/was for you?”) and financial hardship (“How much of a financial 
hardship caring for recipient is/was for you?”). Responses from these three questions on a scale 
from 1 to 5 (1 = not at all strain/stress/hardship; 2 = , 3 = , 4= , 5 = very high 
strain/stress/hardship) were used to develop caregiver burden measure (Kim et al. 2012). Factor 
analysis using Principal Component Analysis showed one factor solution and the reliability 
analysis revealed high Cronbach‟s alpha value (Cronbach‟s alpha for PD sample = 0.74, 
Cronbach‟s alpha for No PD sample = 0.72). Therefore, a composite scale was developed by 
calculating the mean of the three items, where a score of 1 and 5 indicated lowest and highest 
caregiver burden respectively. This method is validated in the existing literature (Kim et al. 
2012). 
Key Independent Variable 
The key independent variable for this study was care-recipients‟ presence or absence of 
PD. Identification of individuals with PD was based on the question in the survey which queried 
what was the “Main problem or illness recipient has/had” for which caregiving was provided.   
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Other Independent Variables 
Characteristics of care-recipients 
The characteristics of care-recipients that were included in this study were: age, sex 
(male/female), living situation (lives in caregiver household, lives elsewhere), number of 
activities of daily living (ADLs) limitations, number of instrumental activities of daily living 
(IADLs) limitations. The six items of ADLs comprised of (a) eating; (b) dressing; (c) bathing; 
(d) toileting; (e) mobility inside own house; and (f) getting in and out of bed. IADLs consisted of 
five activities: (i) grocery shopping; (ii) cooking; (iii) managing money; (iv) taking medications; 
and (v) using the telephone. Number of ADLs and IADLs were used for the purpose of analysis. 
Characteristics of caregivers 
Characteristics of caregivers consisted of age, sex (male/female), and marital status 
(married, unmarried living with others, unmarried living alone). 
Other independent variables 
Other independent variables consisted of number of hours of caregiving per week and 
presence or absence of paid caregivers.  
Cost associated with informal caregiving 
 Costs associated with informal caregiving were calculated by multiplying hours spent on 
informal caregiving by informal caregivers with the estimated market wage rate of a paid 
caregiver (Rakoski et al., 2012). Annual costs were estimated by multiplying each caregiver‟s 
weekly hours of informal caregiving by  52 and the median hourly wage for a home health aide 





 percentile of the cost associated with informal caregiving was also estimated using the 
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Sub-group/Sensitivity Analysis 
 Sub-group analysis was conducted by comparing caregiver burden among caregivers of 
elderly care-recipients with PD to those with Alzheimer's disease, confusion, dementia, and 
forgetfulness.  
Statistical Analyses 
Unadjusted differences in caregiver burden among care-recipients with and without PD 
were determined by using t-tests. Multiple linear regressions were conducted to compare 
caregiver burden and costs after adjusting for care-recipient, caregiver characteristics and other 
independent variables (age of caregiver, sex of caregiver, caregiver marital status, living 
situation of care-recipient, ADLs, IADLs, presence or absence of paid caregiver, and the number 
of hours of caregiving provided per week). Three OLS regression analyses were conducted, 
which utilized informal caregiver burden, number of hours per week of caregiving, and log-
transformed informal cost of caregiving. The cost of informal caregiving was logarithmically 
transformed for the multiple OLS model as the cost data are generally skewed. Dependent 
variable and the independent variables adjusted in the final multivariate analysis were checked 
for missing data, and none of the variables had missing values of more than 5%. Nationally 
representative data were generated by adjusting for population weights in the bivariate and 
multivariate analyses. In the NAC/AARP survey, the population weights were calculated on the 
basis of subset of totally screened respondents in the base study who constituted the original 
individuals who were randomly selected. A single-stage weighting procedure was used to 
achieve the nationally representative estimates. All analyses will be conducted using SAS 9.3 
(SAS Institute, Cary, NC).  
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RESULTS 
 Table 1 displays the care-recipient and caregiver characteristics by presence or absence of 
PD.  
Sample description by care-recipient characteristics 
The mean age of care-recipients with PD was 81.29 (± 6.53) years, while the mean age of care-
recipients without PD was 80.69 (± 8.17). The mean score of ADLs among care-recipients with 
and without PD were 3.14 (± 2.02) and 1.71 (± 1.96) respectively. Care-recipients with PD had a 
mean IADL score of 4.82 (± 2.01), whereas those without PD had a mean score of 4.41 (± 1.84). 
Majority of the care-recipients with (55.8%) and without (68.7%) PD was females.  
Sample description by caregiver characteristics 
 In terms of the caregivers, the mean age of caregivers for care-recipients with and 
without PD was 55.03 (± 14.19) years and 52.05 (± 14.35) years respectively. Majority of the 
caregivers for care-recipients (51.8%) with PD were male, whereas majority of caregivers 
(59.8%) for care-recipients for those without PD were females. Nearly two-thirds of caregivers 
of care-recipients with (67.6%) and without PD (61.3%) were married. Majority of the care-
recipients in both groups lived in places other than the caregiver‟s house. 
Other Independent Variables 
 The mean number of caregiving hours per week reported by caregivers of care-recipients 
with and without PD was 27.51 (± 35.04) hours and 21.62 (± 28.71) hours respectively. Majority 
of the care-recipients with (51.9%) and without (54%) PD did not have a paid caregiver. 
 Table 2 summarizes the unadjusted group differences in caregiver burden by caregiver 
characteristics.  
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Unadjusted group differences by care-recipient characteristics 
Statistically significant differences in caregiver burden were observed by sex of 
caregiver, marital status of caregiver, care-recipient‟s residency status, functional status (ADL 
and IADL), as well as by the presence or absence of a paid caregiver. It was observed that male 
caregivers of care-recipients with PD (2.5 ± 0.25) had higher mean caregiver burden compared to 
the male caregivers of care-recipients without PD (2.02 ± 0.04). Married caregivers of care-
recipients with PD (2.31 ± 0.23) reported a significantly higher average caregiver burden than 
the married caregivers of care-recipients without PD (2.1 ± 0.04). As expected, higher the 
functional limitations (ADL and IADL) of care-recipients, higher were the reported mean 
caregiver burden.  Average number of hours per week of informal caregiving was substantially 
higher among caregivers of care-recipients with PD, who resided within the same household as 
the caregivers as compared to those living elsewhere (55.5 ± 12.27 vs. 12.72 ± 4.3). With the 
increase in the number of functional limitations (ADL and IADL), the number of hours of 
informal caregiving per week also increased significantly in both the groups. Similar findings 
were observed with the annual informal cost of caregiving. 
 Table 3 shows the findings from multiple linear regressions. These regressions were 
adjusted for survey weights. Three multiple linear regression analyses were conducted, which 
utilized caregiver burden, number of hours per week of caregiving, and log-transformed informal 
cost of caregiving. Factors that were adjusted in analysis that used caregiver burden as the 
dependent variable were presence or absence of PD, age of caregiver, sex of caregiver, marital 
status of caregiver, functional status (ADLs and IADLs), presence or absence of a paid caregiver, 
hours per week of informal caregiving and the whether the care-recipient was staying within or 
outside the caregiver house. For the analyses that used number of hours per week of informal 
caregiving and the log-transformed informal cost of caregiving, the factors that were adjusted 
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included presence or absence of PD, age of caregiver, sex of caregiver, marital status of 
caregiver, functional status (ADLs and IADLs), presence or absence of a paid caregiver and the 
whether the care-recipient was staying within or outside the caregiver house. It was observed that 
in all the three different regression analyses, caregiver burden did not differ by the presence or 
absence of PD. ADLs and IADLs were consistently positively associated with caregiver burden 
in all the three models. Female caregivers were also found to be significantly more likely to 
experience higher caregiving burden compared to male caregivers in all the three models. 
Cost associated with informal caregiving 
 The median wage of a home health aide ($10.10) for 2013 was obtained from the Bureau 
of Labor Statistics. Using this median wage and the mean number of hours of caregiving (Table 
1), the national yearly informal cost of caregiving for care-recipients with and without PD was 





hourly wage value of a home health aide are $8.03 and $14.17 respectively. Using this wage 
values, the national yearly informal caregiving costs ranged between $11,500 and $20,300 for 
care-recipients with PD, while that of care-recipients without PD ranged between $9,050 and 
$16,000 (all wage values rounded up). 
Sub-group/Sensitivity analysis 
 Sub-group analysis was conducted by comparing the caregiver burden among caregivers 
of care-recipients with PD and those with Alzheimer's disease, confusion, dementia, and 
forgetfulness. After adjusting for all the care-recipient, caregiver and other independent 
variables, it was observed that the caregiving burden did not differ between these two groups (β 
= -0.25, p = 0.1091). 
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DISCUSSION 
 Using a nationally representative sample of caregivers in the United States (U.S.), the 
present study examined the informal caregiver burden and cost associated with caregiver burden 
among care-recipients with and without PD. To the best of author‟s knowledge, this is the first 
nationally representative study comparing informal caregiving burden and costs among care-
recipients with and without PD. The study hypothesized that, informal caregiving burden will be 
higher among those who provided care to elderly individuals with PD compared to caregivers of 
elderly without PD, due to special needs of elderly individuals with PD in terms of limitations of 
ADLs, IADLs, motor and non-motor symptoms, cognitive impairment and behavioral issues 
(Noyes et al., 2006; Whetten-Goldstein et al., 1997). However, findings from this nationally 
representative study revealed that there were no significant differences in caregiving burden 
among caregivers of care-recipients with and without PD. Although the caregivers of elderly 
individuals with PD spent 1.4 times more hours in providing informal care compared to 
caregivers of elderly without PD, the difference was not statistically significant. This lack of 
statistical significance could be due to the small sample size of the care-recipients with PD. For 
example, post-hoc power analysis revealed that a minimum of 373 elderly individuals in each 
group will be needed to detect a statistically significant difference. 
 A noteworthy finding in our study is the association between the functional status of the 
care-recipients and caregiver burden. It was observed that ADL and IADL were significantly 
positively associated with caregiver burden in all the three models. For instance, in Model 2, for 
each unit increase in ADL, the number of hours of informal caregiving per week will increase by 
4.468 units (β = 4.468, S.E. = 0.398, p < 0.001).  Similarly, in Model 2, for each unit increase in 
IADL, the number of hours of informal caregiving per week will increase by 2.755 units (β = 
2.755, S.E. = 0.343, p < 0.001). These findings are consistent with earlier studies conducted by 
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Edwards & Ruettinger (2002) and Cifu et al., (2006), who observed that higher caregiver burden 
was associated with increased difficulties with ADL performance. Although prior studies have 
not examined the relationship between IADL and caregiver burden, our study documents that 
increase in the number of difficulties with IADLs was also associated with greater caregiver 
burden. 
 The average hours per week of caregiving for care-recipients with PD was estimated to 
be 27.51 (±35.04) hours as compared to 21.62 (±28.71) hours. Therefore, caregivers of care-
recipients with PD spent substantially higher number of hours per week in caregiving compared 
to those without PD. A study conducted by Parrish et al. (2003) found that informal caregivers 
spent 96 hours/week in caregiving of care-recipients with PD. The average number of hours of 
caregiving per week from the current study is considerably lower compared to the Parrish et al. 
study. The study conducted by Parrish et al. (2003) was geographically limited as it was 
conducted only in California and hence the findings from this study provides the estimate of 
national average of hours per week of caregiving for care-recipients with PD. The high amount 
of time spent on caregiving can lead to serious stress among caregivers and it has been in 
documented in the existing literature that if more than 16 hours of caregiving per week is 
provided, it leads to higher rates of nursing home placements of the care-recipients (Etters, 
Goodall, & Harrison, 2008). 
 One of the unique contributions of this study is that it provided a nation-wide estimation 
of costs associated with informal caregiving of for elderly individuals PD. Additionally, this 
study compared costs associated with informal caregiving of care-recipients with and without 
PD. It was found that the costs associated with informal caregiving of care-recipients with PD 
were 1.27 times higher than care-recipients without PD. The high annual costs of informal care 
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provided to the elderly individuals with PD have significant financial implications. With the 
aging population of U.S. and the consequent expected increase in the number of individuals with 
PD, efforts need to be devoted towards reducing informal caregiving burden.  
 Findings from this study also revealed that female caregivers are significantly more likely 
to experience caregiver burden compared to male caregivers. This is consistent with the finding 
from Edwards & Scheetz (2002) study where female caregivers reported double the burden as 
compared to male caregivers. In general, the prevalence of PD is higher among men which in 
turn influences the gender of caregivers, and it has been observed in existing studies (Edwards & 
Scheetz 2002) as well as in this study that the number of female caregivers are higher among the 
care-recipients of PD. Some of the reasons that we can speculate to explain the increased 
caregiving burden among female caregivers may include the perception of not taking adequate 
care of the care-recipients despite being the sole caregivers in most cases (Hooker et al. 2000). 
Moreover, female caregivers sometimes believe that they are responsible for the condition of the 
care-recipients (Hooker et al. 2000).  
 In this study, it was also indicated that use of paid caregiver is negatively associated with 
caregiver burden. This finding is intuitive as the use of paid caregivers can lead to reduced 
caregiving burden among informal caregivers. Existing studies did not account for paid 
caregivers as one of the individual level variables. 
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Strengths/Limitations 
 Some of the strengths of this study include nationally representative sample of elderly 
care-recipients and their caregivers, ability to identify PD, and comprehensive list of variables 
for both care-recipients and caregivers from survey data. 
However, there are some limitations of this study. The study sample was small with only 
32 caregivers of care-recipients with PD. This small sample size may affect the power of the 
analyses. This data did not have information related to clinical factors such as the presence of 
physical (e.g. diabetes) and/or mental conditions (e.g. depression, anxiety). Adjusting for 
comorbid conditions may explain more variance in the caregiver burden. Moreover, duration and 
severity of diseases was available. However, ADLs and IADLs may serve as global proxies for 
severity of illness. Additionally, as this is a survey, presence of recall bias cannot be ruled out. 
CONCLUSION 
 This is the first nationally representative study of caregiver burden among care-recipients 
with PD. No significant differences were observed among in terms of caregiver burden among 
caregivers of care-recipients with and without PD. However, findings from this study suggest 
that caregivers of care-recipients with PD experience higher burden in terms of number of hours 
of caregiving provided per week and also higher annual costs of informal caregiving. Number of 
ADLs and IADLs explained most of the variance in caregiver burden. Thus findings from this 
study suggest that several factors need to be taken into consideration while developing an 
appropriate intervention to help caregivers deal with their caregiver burden. 
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Table 1: Demographic characteristics of Caregivers and Care-recipients of Elderly Individuals 
with and without PD 
National Alliance for Caregiving, 2004, 2009, N= 1,671 
  
PD 




   Care-recipient characteristics 
     
  
Mean ± S.D 
 
Mean ± S.D 
  Age (years) 81.29 ± 6.53 
 
80.69 ± 8.17 
  ADL score 
 
3.14 ± 2.02 
 
1.71 ± 1.96 
 
** 
IADL score 4.82 ± 2.01 
 
4.41 ± 1.84 
  Caregiver characteristics 
     Age (years) 55.03 ± 14.19 
 
52.05 ± 14.35 
  Other Independent Variables      
Hours of caregiving per week 27.51 ± 35.04  21.62 ± 28.71   
Care-recipient characteristics      
Gender 
 
N  Col % N Col % 
 
 
Male 15 40.7 468 29.8 
 
 
Female 16 55.8 1,147 68.7 
 
 
Missing 1 3.5 24 1.6 
 Caregiver characteristics      
Gender 
 
N  Col % N Col % 
 
 
Male 15 51.8 594 40.2 
 
 
Female 17 48.2 1,045 59.8 
 Marital status 
     
 
Married 21 67.6 999 61.3 
 
 
Others 11 32.4 640 38.7 
 Living status of care-recipient 
     
 
Lives in CG household 11 35.3 381 19.2 * 
 
Lives elsewhere 21 64.7 1,258 80.8 
 Other Independent Variables 
     Paid Caregiver 
     
 
Yes 17 48.1 728 46.0 
 
 
No 15 51.9 911 54.0 
 Note: Based on 1,671 elderly care-recipients aged 65 or older. 
CG: Caregiver; ADL: Activities of daily living; IADL: Instrumental activities of daily living 
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Table 2: Caregiver Burden (Mean and Standard Deviations) by Caregiver and Other Characteristics 
National Alliance for Caregiving, 2004, 2009, N= 1,671 
  
CG Burden Scale † Number of hours/week ‡ Informal CG cost ǂ 
  
PD No PD Sig PD No PD Sig PD No PD Sig 
  
N=32 N = 1,639 
 
N=32 N = 1,639 
 
N=32 N = 1,639 
 Characteristics 
         Sex of Caregiver 
  
* 
      
 
Female 1.95 ± 0.29 2.25 ± 0.04 
 
20.56 ± 8.29 21.26 ± 0.98 
 
10,798 ± 4,358 11,166 ± 517 
 
 
Male 2.5 ± 0.25 2.02 ± 0.04 
 
34.57 ± 9.91 18.2 ± 1.22 
 
18,158 ± 5,203 9,560 ± 639 
 Marital Status of Caregiver 
         
 
Married 2.31 ± 0.23 2.1 ± 0.04 
 
26.19 ± 8.26 19.24 ± 0.96 
 
13,579 ± 4,340 10,107 ± 503 
 
 
Others 2.08 ± 0.39 2.24 ± 0.05 
 
31.18 ± 11.44 21.28 ± 1.26 
 
16,381 ± 6,010 11,174 ± 670 








 Lives in CG household 2.44 ± 0.33 2.63 ± 0.06 
 
55.5 ± 12.27 47.46 ± 2.19 
 
29,151 ± 6,446 24,926 ± 1,151 
 
 
Lives elsewhere  2.13 ± 0.25 2.04 ± 0.03 
 
12.72 ± 4.3 13.52 ± 0.67 
 









None 1.15 ± 0.15 1.77 ± 0.04 
 
11.59 ± 5.42 9.85 ± 0.63 
 
6,090 ± 2,844 5,170 ± 333 
 
 
"1-2" 1.97 ± 0.42 2.06 ± 0.05 
 
26.13 ± 13.71 16.35 ± 1.18 
 
13,723 ± 7,198 8,587 ± 620 
 
 
3, + 2.67 ± 0.18 2.75 ± 0.06 
 
33.22 ± 9.18 37.57 ± 1.77 
 









Noneǂ 1.66 1.58 ± 0.19 
 
2.00 3.78 ± 1.81 
 
1,050  1,987 ± 953 
 
 
"1-2"  1.89 ± 0.51  1.61 ± 0.05 
 
 4.35 ± 0.79  7.75 ± 1.17 
 
 2,283 ± 413  4,069 ± 615 
 
 
3, + 2.32 ± 0.23  2.28 ± 0.03 
 
32.83 ± 7.68  23.07 ± 0.88  17,241 ± 4,032  12,115 ± 463 
 Presence of Paid Caregiver 





Yes 2.2 ± 0.27 2.3 ± 0.05 
 
25.11 ± 10.01 21.74 ± 1.24 
 
13,188 ± 5,258 11,420 ± 653 
 
 
No  2.27 ± 0.31 2.03 ± 0.04 
 
 30.32 ± 8.96 18.57 ± 0.94 
 
 15,924 ± 4,708 9,754 ± 493 
 Note: †Dependent variable was the computed Caregiver Burden 
‡Dependent variable was the number of hours spent in caregiving per week 
ǂ Dependent variable was the cost of informal caregiving in terms of 2013 US dollars 
 
ADL: Activities of daily living; IADL: Instrumental activities of daily living 
*** p < .001;  **.001 ≤ p < .01; *  .01 ≤ p < .05 
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Table 3: Parameter Estimates and Standard Errors from Ordinary Least Square Regressions on Caregiver Burden, 
Number of Caregiving Hours and Log-transformed Costs Associated with Informal Care giving  
National Alliance of Caregivers Survey (2004, 2009), N = 1,671 
  
CG Burden Scale† Number of hours/week‡ 
Log-transformed 
Informal CG Cost ǂ 
Characteristics Beta S.E. Sig Beta S.E. Sig Beta S.E. Sig 
 
Intercept 0.985 0.101 *** -13.005 2.382 *** 6.598 0.132 *** 
Parkinson's disease 
         
 








         Age of Caregiver 0.003 0.002 
 
0.175 0.042 *** 0.006 0.002 ** 
Sex of Caregiver 
         
 
Female 0.173 0.049 *** 2.316 1.155 * 0.170 0.057 ** 
 
Male 
         Marital Status of Caregiver 
         
 
Married -0.103 0.051 * -0.667 1.210 
 
-0.132 0.057 * 
 
Others 
         Care-recipient residency status 
         
 
 Lives in Caregiver household -0.031 0.071 
 
23.413 2.267 *** 0.836 0.077 *** 
 
Lives elsewhere 
         ADLS 0.132 0.015 *** 4.468 0.398 *** 0.207 0.015 *** 
IADLS 0.139 0.015 *** 2.755 0.343 *** 0.258 0.018 *** 
Presence of Paid Caregiver 
         
 
Yes 0.104 0.049 * -0.965 1.200 
 
-0.178 0.057 ** 
 
No 
         Number of hours spent in 
caregiving/week 0.006 0.001 *** - - 
 
- -  
          
Note: PD = 32, No PD = 1,639 
†Dependent variable was the computed Caregiver Burden; This model was adjusted for presence or absence of PD, 
Age of caregiver, Sex of caregiver, Marital status of caregiver, care-recipient‟s residency status, ADL, IADL, 
presence or absence of paid caregiver, number of hours spent in caregiving per week 
‡Dependent variable was the number of hours spent in caregiving per week; This model was adjusted for presence 
or absence of PD, Age of caregiver, Sex of caregiver, Marital status of caregiver, care-recipient‟s residency status, 
ADL, IADL, presence or absence of paid caregiver 
ǂ Dependent variable was the log-transformed cost of informal caregiving; This model was adjusted for presence or 
absence of PD, Age of caregiver, Sex of caregiver, marital status of caregiver, care-recipient‟s residency status, 
ADL, IADL, presence or absence of paid caregiver 
 
ADL: Activities of daily living; IADL: Instrumental activities of daily living 


















Page 86 of 129 
 
CHAPTER 4: Chronic Illness with Complexity: Diabetes Care among Elderly Medicare 
Beneficiaries with Parkinson’s disease and Diabetes 
 
INTRODUCTION 
Chronic Illness with Complexity (CIC) 
 According to the National Quality Forum (NQF) and the Agency for Healthcare Research 
and Quality (AHRQ) , CIC is defined as “two or more chronic conditions that have an adverse 
effect on health status, function status, or quality of life of the patient and require complex 
coordination of care” (http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifie). Due to 
the presence of multiple morbidities, individuals with CIC are at a higher risk of limitations of 
activities of daily living and disability (Weiss, 2007).  
 CIC is highly prevalent and has been increasing over time. In 2009, 145 million 
(approximately half the United States population) Americans had one or more chronic 
conditions, among which nearly half and more than a quarter of the individuals with chronic 
conditions had multiple morbidities (chronic care chart book). According to the National Health 
Interview Survey (NHIS) 2010, among elderly men 45.4% had 2-3 chronic illness and 17.1% 
had four or more chronic illness, whereas among elderly women 47.4% had 2-3 chronic illness 
and 14.5% had four or more chronic illness (NHIS 2010). Findings from 2009 MEPS revealed 
that among elderly individuals 42.5% had 2-3 chronic illness while 24.6% had four or more 
chronic illness (chronic care chart book). 
CIC is associated with a wide array of negative health outcomes such as limitations of 
functional status, decreased health-related quality of life, higher healthcare expenditures, greater 
disability, adverse drug events, duplicative tests, contradictory medical advice, and lower 
survival rates (Condelius, Edberg, Jakobsson, & Hallberg, 2008; Fortin, Bravo, Hudon, Vanasse, 
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& Lapointe, 2005; Fortin, Soubhi, Hudon, Bayliss, & van, 2007; Gijsen et al., 2001; Marengoni, 
von Strauss, Rizzuto, Winblad, & Fratiglioni, 2009; Schneider, O'Donnell, & Dean, 2009; van, 
Buntinx, Metsemakers, Roos, & Knottnerus, 1998). For example, the average annual healthcare 
expenditures among elderly individuals with two to three and four or more chronic illness was 
estimated to be US$8,979 and US$15,553 (2006 US dollars) respectively (chronic care chart 
book). 
Chronic Illness with Complexity:  Co-occurring Parkinson’s Diseases and Diabetes 
T2DM and its complications (micro- and macro-vascular) are the leading causes for 
morbidity and mortality in the United States (U.S.) (Shaw, Sicree, & Zimmet, 2010). Parkinson‟s 
disease (PD) is a progressive neurodegenerative disease characterized by muscular tremor, 
slowing of movement, partial facial paralysis, peculiarity of gait and posture (Muangpaisan et al., 
2011; Park & Stacy, 2009). According to the definition of CIC provided by AHRQ and NQF, co-
occurring T2DM and PD can be considered as CIC their co-occurrence severely affects the 
quality of life, and impairs health and functional status. Moreover, co-occurring T2DM and PD 
require medical care from different specialties such as neurologists and endocrinologist, and 
require care in different settings including home-based as well as facility-based care (Lapane, 
Fernandez, & Friedman, 1999; Nocera, Horvat, & Ray, 2009). It has to be noted that the 
prevalence of T2DM among elderly individuals with PD is comparable or slightly lower 
compared to those without PD. A study conducted among elderly Medicare beneficiaries showed 
that the prevalence rate of metabolic conditions did not differ significantly between individuals 
with and without PD (Noyes, Liu, Li, Holloway, & Dick, 2006). Another study conducted among 
a nationally representative sample of community-dwelling elderly individuals in the United 
States found that the prevalence of T2DM was actually lower among individuals with PD 
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compared to matched controls without PD (Bhattacharjee & Sambamoorthi, 2013). However, it 
has been estimated that by 2030, the prevalence of both T2DM and PD will increase by 
approximately two-folds due to the aging U.S. population (Dorsey et al. 2007) and will become a 
major public health concern in the near future.  
Need for the study 
Chronic Illness with Complexity:  Diabetes Process and Outcomes 
  Co-occurring PD and diabetes can pose significant challenges to diabetes management. 
However, clinical guidelines for diabetes management for those with CIC are lacking. In general, 
guidelines for clinical practice are developed based on the expert consensus and the scientific 
evidence for a single disease state (Boyd et al., 2005). Standards of care and quality of care 
improvement efforts are based on these guidelines for clinical practice. As for example, there are 
separate guidelines for treating diabetes (such as the guidelines of the American Diabetes 
Association) and PD (European Parkinson's Disease Standards of Care Consensus Statement).  
Furthermore, studies on diabetes care among individuals with CIC have revealed mixed 
findings. One study conducted among veterans with diabetes seeking care in seven different 
Veterans Affairs (VA) facilities from July 2007 through June 2008 reported that veterans with 
CIC were more likely to receive overall good quality for all three quality measures (glycemic, 
blood pressure and low density lipoprotein-cholesterol control) combined (adjusted OR, 2.17; 
95% CI, 1.96-2.39) (Woodard, Urech, Landrum, Wang, & Petersen, 2011). Whereas, another 
study using the INTERMED classification system for case complexity found that greater 
complexity among individuals with T2DM was associated with higher HbA1c values (Fischer et 
al., 2000).  Therefore, the aim of this study was to assess process and intermediate clinical 
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outcomes of diabetes care among elderly individuals with CIC (T2DM and PD) compared to 
those without CIC (T2DM without PD). 
Conceptual Framework 
The current study adapts elements from the Vector model of Complexity proposed by 
Safford and colleagues (Safford, Allison, & Kiefe, 2007). This framework allows one to examine 
CIC with different factors such as socio-economic (e.g. insurance status), cultural (e.g. 
race/ethnicity), biological/genetic (e.g. gender), external environmental (e.g. region), and 
healthcare use (e.g. co-medication use) contributing to complexity. Patient complexity can occur 
from any axis, but primary focus is often given on the underlying biological axis by physicians. 
Each of the axes in this model is interconnected with the other as depicted by the web, and even 
in case of not being connected by adjacent web, the axes are still connected with each other.  
Page 90 of 129 
 













                   
 
                   
                                                      
 
 




Cultural      Provider & health systems 
 






























 A retrospective cohort design (2007-2008, 2008-2009, 2009-2010, 2010-2011) using 
matched case-control approach with observational data was used for the purposes of this study. 
For each elderly individual with T2DM, the observation period consisted of 24 months with 12-
month baseline period and 12-month follow-up period. For example, if T2DM and PD cases 
were identified in 2007, 2007 served as the baseline year, and 2008 served as the follow-up 
period. Process of care and intermediate clinical outcomes were measured during the follow-up 
year (i.e. 2008). 
Data Source  
 The Humana Medicare Advantage Part D database (MAPD) from January 2007 through 
December 31, 2011 was used for this study. The Humana claims database consists of more than 
12 million current and previous enrollees among which 1.9 million enrollees are from MAPD 
plans.  This study used medical, prescription, laboratory claims and person enrollment summary 
files. The medical claims contained information related to the type of plan, treatment date, type 
of admission (trauma, elective, emergency etc.), inpatient length of stay, diagnosis and 
procedural codes, and total Medicare allowable charges associated with each claim. Prescription 
claims included information on prescription fill date, medication dispensed, quantity of 
medication dispensed, net amount paid by Humana and out-of-pocket costs for enrollees.. The 
laboratory Claims contained information on lab test identifying codes, lab results and abnormal 
value indicator. However, laboratory results are available only for approximately 30% of the 
laboratory claims. The patient enrollment summary file included information on the MAPD 
enrollees age, sex, race/ethnicity, and enrollment dates.  
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Study Population  
The study population consisted of elderly Medicare beneficiaries (≥65 years) with 
T2DM. Elderly Medicare beneficiaries with T2DM were identified by the presence of a 
minimum of one inpatient or two outpatient visits (at least of 30 days apart) with a primary or 
secondary diagnosis of T2DM [International Classification of Diseases 9
th
 Modification (ICD-9-
CM) code: 250.x0 or 250.x2] (Wang, Wei, Miao, Xie, & Baser, 2013; Xie et al., 2013).  
Inclusion Criteria: 
Other inclusion criteria were: (i) continuous enrollment of 24 months (at baseline and 
follow-up year); and (ii) receipt of at least one oral antidiabetic drug (OAD) or insulin during the 
baseline year.  
Dependent Variables 
Process of Care 
 The three processes of care measures used in this study included: (i) HbA1c testing; (ii) 
lipids testing; and (iii) nephropathy screening. These measures were considered to meet the 
American Diabetes Association (ADA) guidelines if: (1) HbA1c testing was conducted at least 
two times a year with a gap of at least three months; (2) lipid testing was conducted at least once 
a year; and (3) nephropathy screening was conducted at least once a year. A detailed description 
of the CPT and HCPCS codes are provided in Appendix I. 
Intermediate Clinical Outcomes 
Glycemic control 
  
 HbA1c > 9% represents poor glycemic control and is considered to be a poor 
performance marker among all elderly individuals with CIC (Meduru 2007). One study has used 
HbA1c < 7% is representative of optimal glycemic control (Meduru et al., 2007). However, 
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among elderly individuals HbA1C < 8% is often considered as acceptable glycemic control 
(HEDIS. Technical Specifications). Therefore, glycemic control outcomes were classified into 
three groups based on HbA1c values as follows: (i) < 8%; (ii) ≥ 8%. This outcome was measured 
only among those with HbA1c values.  
Lipid Control 
Lipid control outcomes were based on Low Density Lipoprotein Cholesterol (LDL-C), 
High Density Lipoprotein Cholesterol (HDL-C), triglycerides, and total cholesterol. These lipid 
control outcomes were categorized based on the American Diabetes Association guidelines. 
LDL-C was categorized as follows: (i) <100 mg/dl; (ii) ≥ 100 mg/dl and (iii) no LDL-C value. 
HDL-C was categorized into two groups for both men and women as follows: (i) ≤ 40 mg/dl for 
men; (ii) > 40 mg/dl for men; (iii) ≤ 50 mg/dl for women; and (iv) > 50 mg/dl for women. 
Triglycerides were classified into two groups as follows: (i) <150 mg/dl; (ii) ≥ 150 mg/dl, and 
(iii) no triglyceride values. Total cholesterol was divided into groups as follows: (i) < 200 mg/dl; 
(ii) ≥ 200 mg/dl (ADA guidelines).  Again these were restricted to individuals with available 
laboratory values. 
Key Independent variable: Presence of PD 
 The key independent variable for all analyses was presence or absence of PD. 
Identification of PD was achieved by using ICD-9-CM code of 332.xx during the baseline year. 
The diagnosis of PD was ascertained by the presence of at least one inpatient or two outpatient 
visits (30 days apart) with a primary or secondary diagnosis of PD (ICD-9-CM code: 332.xx). 
PD cases were matched with those without PD using propensity scores generated by conducting 
a logistic regression on presence/absence of PD which adjusted for gender, age, and diabetes 
complications severity index (DCSI). One case was matched to three controls based on 8 to 1 
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GREEDY matching technique using propensity score. For 8 to 1 GREEDY matching, the cases 
and control with same propensity score till the 8
th
 digit are matched, and if they do not match on 
8 digits, then it goes to 7-digit matching and so on. The GREEDY matching technique employs a 
sample without replacement algorithm and if there are more than one matches, then selection of 
control becomes random. Additionally, it was ensured that controls should be from the same 
calendar year as the cases (i.e. if individuals were identified with PD in 2008, all controls will be 
from 2008).  
Independent variables 
Patient Complexities 
According to the American Geriatric Society (AGS) guidelines, individuals having 
specific conditions such as cognitive impairment, depression, fall and falls risk, polypharmacy, 
and urinary incontinence should be provided individualized treatment (Inouye et al. 2007). These 
characteristics were measured during the baseline period. Elderly Medicare beneficiaries were 
considered to have cognitive impairment due to physical illnesses if they had a diagnosis of 
Huntington‟s disease, delirium, dementia, amnestic and other cognitive disorders; whereas if 
they have a diagnosis of bipolar disorder, schizophrenia and other psychotic disorders, they were 
considered to have cognitive impairment due to mental illnesses. Elderly Medicare beneficiaries 
were considered to have any cognitive impairment if they had either mental and/or physical 
cognitive impairment. To identify accidental falls, E-codes E880 through E888 were used 
whereas V-code V15.88 was used as a proxy measure for falls risk (Mehta et al. 2010; Tinetti et 
al. 2006). Number of therapeutic classes of prescribed medications was used to define 
polypharmacy, and was categorized into quintiles: (i) 0-0, (ii) 1-1, (iii) 2-3, (iv) 4-5, and (v) 6-31.  
 
 
Page 95 of 129 
 
Dominant Comorbid Conditions 
 Using the framework of Kerr and Piette, cancer, end stage renal disease, and end stage 
liver disease were included as a dominant comorbid condition in this study (Piette et al. 2006).  
Other independent Variables 
Other independent variables consisted of socio-economic, cultural, and 
environmental/ecological variables. Socio-economic variables consisted of (i) Medicare 
prescription drug coverage gap; and (ii) insurance status (Private Fee-for-service, Health 
Maintenance Organization, and other insurance). Environmental factors consisted of (i) region 
(South, Mid-West, and Other regions). The cultural factor was defined by race/ethnicity (Whites, 
African- Americans, Hispanics, and Others).  
Statistical Analyses 
Unadjusted differences among elderly individuals with and without Parkinson‟s disease 
were determined using chi-square tests. Conditional Logistic regression analyses and conditional 
multinomial logistic regression analyses were conducted for binary dependent variables and 
dependent variables with more than two levels respectively. As 30% of the study cohort did not 
have laboratory values, sample selection models were also conducted to test selection bias 
among individuals with and without laboratory values. This was accomplished using “Heckprob” 
selectivity corrected regression.  These models consisted of a selection equation in which the 
presence or absence of laboratory values were modeled.  In the outcome equation, the 
intermediate outcomes were modeled. For example, for HbA1c control, a logistic regression 
analysis on the presence or absence of HbA1c values was conducted.  In the outcome equation, 
glycemic control (<8% and > 8%) was modeled. The Wald test of independence showed that the 
chi-square probability value was 0.7968 indicating that there is no influence of unobserved 
variables on glycemic control outcome in this dataset. Similar findings were observed with the 
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lipid outcomes. Therefore, we report results from analyses among elderly individuals with 
available HbA1C values and lipid values. 
Propensity Score Matching 
Before propensity score matching, there were 2,727 individuals with PD and diabetes 
(cases), and 249,763 individuals with diabetes only (controls). After propensity score matching 
and removing pairs with inexact matches, there were 2,703 individuals with PD and diabetes and 
8,109 individuals with diabetes only (1:3 case to control matching). The cohort development is 
depicted in Figure 1. Age (in years) and Diabetes Complications Severity Index (DCSI) total 
were continuous variables and the group differences in these two variables were ascertained by t-
tests. For gender the group differences were ascertained by using chi-square. The number of 
individuals with Parkinson‟s disease (PD) and before and after matching in each year are 
different because of the fact that we found that 1,282 individuals without PD in previous years 
were diagnosed with PD in the following year, and as these individuals were included in the 
control dataset for a particular year, they were deleted from the control dataset so that we do not 
have overlap between case and control group during matching. For each year, the individuals 
with PD in the matched sample were unique cases. 
The two groups were matched on age, gender and DCSI scores. The c-statistics of the 
logistic regression to calculate propensity score for each year were found to be satisfactory 
(around 0.70). From Table 1, it can be noted that, before propensity score matching, the two 
groups differed significantly from each other in terms of age, DCSI total and gender distribution. 
Before matching, among individuals with T2DM and PD, the total mean DCSI score was 
significantly higher compared to those with only diabetes. In terms of age, individuals with PD 
and diabetes had a significantly higher mean age as compared to those with diabetes only prior to 
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propensity score matching. The PD and diabetes group had significantly higher number of males 
as compared to the group with diabetes only before matching. The propensity score matched 
sample was found to be well balanced in terms of the variables that were used to match the two 
groups. After matching there were no significant differences between the two groups in terms of 
age, DCSI and gender. From Table 2, it can be noted that when the 4 panels (2007-2008, 2008-
2009, 2009-2010, and 2010-2011) were stacked, there were no statistically significant group 
differences in terms of age, gender and DCSI.  
RESULTS 
Description of Study Sample by PD status 
Table 3 exhibits baseline characteristics of T2DM elderly individuals with and without 
PD. There was significantly higher proportion of African-Americans (14.4%) among individuals 
with only diabetes. Overall, both the groups (individuals with T2DM and PD and with diabetes 
only) had higher proportions of whites (75.7% and 74.3% respectively). In terms of region and 
plan types, there were higher proportion of individuals in the South region (around 75%) and 
Health Maintenance Organizations in both the groups (around 48%). There was significantly 
higher proportion of individuals who did not reach donut hole (56.6%) among individuals with 
only diabetes, whereas the group with PD and diabetes had higher proportions of individuals 
entering (44.9%) and having entry and exit information regarding donut hole (17.7%). 
Individuals with PD and diabetes had significantly greater proportion of polypharmacy users in 
the higher quintiles (4-5, and 6-31). With respect to the conditions specific to elderly individuals, 
individuals with PD and diabetes had significantly higher proportion of urinary incontinence 
(10.4%), major depressive disorders (26.7%), cognitive impairment (33.4%), and falls and falls 
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risk (9.9%). Individuals with PD and diabetes had a higher proportion of baseline emergency 
room (55.5%) and baseline home health visit (60.9%). 
Description of Process of Care and Intermediate Clinical Outcomes 
Table 4 summarizes the findings in terms of process of care measures and intermediate 
clinical outcomes. Overall, 66.84% had ADA recommended HbA1c testing. A lower percentage 
of individuals with T2DM and PD received HbA1c testing (63.7%) compared to those with 
T2DM and no PD (67.9%, P-value <0.001).  
An overwhelming majority of individuals with T2DM received lipid testing (84.65%). A 
lower percentage of elderly individuals with T2DM and PD (80.4%) received lipid testing 
compared to those with T2DM and no PD (86.1%, p-value < 0.001). No statistically significant 
differences were observed in the two groups in terms of nephropathy screening.  
Among elderly individuals with available HbA1C values, an overwhelming majority had 
HbA1C value of < 8% in both individuals with T2DM and PD (86%) and T2DM and no PD 
(83.8%). Elderly individuals with T2DM and PD had statistically significantly better 
intermediate clinical outcomes compared to those with T2DM and no PD in terms of LDL-C< 
100mg/dl (75.5% vs. 69.8%), triglycerides < 150mg/dl (63.8% vs. 58.6%), total cholesterol < 
200mg/dl (87.2% vs. 83%) and HDL-C ≥ 50mg/dl (39.8% vs. 35.7%).  
Multivariable Conditional Logistic Regression on Process of Care 
Table 5 shows the results of conditional logistic regression analyses conducted with 
HbA1c testing as the dependent variable adjusting for the matched pair design. After controlling 
for Parkinson‟s disease, race/ethnicity, region, plan-type, donut hole, polypharmacy, urinary 
incontinence, depression, falls and fall risk, cognitive impairment due to physical conditions, 
cognitive impairment due to mental conditions, dominant conditions, baseline emergency room 
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visits, baseline home health visits and adjusting for the matched pair design, it was observed that 
individuals with PD and diabetes were 12% (AOR: 0.88, 95%CI: 0.79-0.97) and 18% (AOR: 
0.82, 95%CI: 0.72-0.94) less likely to meet the annual ADA recommended HbA1c and lipid 
testing respectively compared to individuals with diabetes and without PD. However, there were 
no statistically significant difference between individuals with and without PD in terms of 
nephropathy testing (AOR: 0.99, 95%CI: 0.88-1.10).  
Table 6 depicts the results from conditional multinomial logistic regression with 
glycemic control as the dependent variable. After adjusting for Parkinson‟s disease, 
race/ethnicity, region, plan-type, donut hole, polypharmacy, urinary incontinence, depression, 
falls and fall risk, cognitive impairment due to physical conditions, cognitive impairment due to 
mental conditions, dominant conditions, baseline emergency room visits, baseline home health 
visits and matched pair design, it was observed that individuals with T2DM and PD were 34% 
(AOR: 1.34, 95%CI: 1.10-1.63) more likely to have better glycemic control (HbA1c < 8%) 
compared to those with T2DM and without PD. Individuals with T2DM and PD were higher 
likely to have better outcomes in terms of LDL-C (<100mg/dl) (AOR: 1.29, 95%CI: 1.06-1.59), 
triglyceride (<150mg/dl) (AOR: 1.31, 95%CI: 1.06-1.62), total cholesterol (<200mg/dl) (AOR: 
1.46, 95%CI: 1.08-1.97) and HDL-C (≥ 50mg/dl) (AOR: 1.20, 95%CI: 1.04-1.39). 
DISCUSSION 
 This study examined the association between CIC and process and intermediate outcomes 
of diabetes care among elderly individuals with T2DM. CIC was defined as the co-occurrence of 
T2DM and PD. Results from this study indicated that among individuals with T2DM, those with 
PD did not receive the ADA recommended HbA1c and lipid testing compared to those without 
PD. These findings suggest that, CIC is a barrier to achieving clinically recommended process of 
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care measures. Some of the reasons which may lead to not achieving the ADA recommended 
HbA1c and lipid testing can be that elderly Medicare beneficiaries may not be aware of the 
benefits of meeting these goals, or there can be a gap in patient-provider communication, or the 
elderly Medicare beneficiaries may not be visiting their physicians on a regular basis (Delaronde, 
2005). Some ways in which these barriers can be overcome include educating patients and 
underscoring and helping in attending group consultations by healthcare providers (Van Dam et 
al. 2003). Moreover, for managed care settings, telephone follow-up and/or reminders have been 
seen to be effective (Rubin, Dietrich & Hawk, 1998). Another plausible reason for not achieving 
ADA recommended goals may be due to competing demands of elderly Medicare beneficiaries 
with T2DM and PD. It is possible that the severity of PD may be high in this group of patients 
and providers might be focusing on treating PD than T2DM. However, as the measure of 
severity of PD in claims database is not available, this remains one of the unmeasured factors 
that can be influencing the study findings.  
A noteworthy finding from our study is the relationship between CIC and intermediate 
clinical outcomes of diabetes care. For glycemic and lipid outcomes, elderly individuals with 
T2DM and PD were more likely to achieve control compared to those with T2DM and no PD. A 
plausible explanation for better outcomes among those with T2DM and PD could be due to 
pathophysiological conditions of the two diseases. For example, it has been suggested that 
insulin resistance and insulin deficiency, which are the cardinal characteristics of T2DM, can 
lead to neurodegeneration (Peila, Rodriguez, White, & Launer, 2004; Rönnemaa et al., 2008; 
Rönnemaa et al., 2009). It is possible that given the risk of neurodegeneration due to T2DM, the 
providers may be aggressively treating individuals with T2DM and PD for better glycemic and 
lipid outcomes in order to prevent further neurodegeneration. The findings from this study are 
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consistent with a study conducted among elderly veterans, which showed that veterans with CIC 
were more likely to receive overall good outcomes for all 3quality measures (glycemic, blood 
pressure and low density lipoprotein-cholesterol) combined (adjusted OR, 2.17; 95% CI, 1.96-
2.39) (Woodard, Urech, Landrum, Wang, & Petersen, 2011). One of the similarities between VA 
and the Medicare Advantage plans is that they follow the Integrated Delivery System (IDS) 
model. In the IDS model, the primary physician serves as the gate-keeper and maintains proper 
referral systems. The coordination of care among different types of specialists (Endocrinologists, 
Neurologists etc.) is ensured in the IDS models which in turn could lead to better management of 
individuals with CIC. The consistent finding of better glycemic and lipid outcomes among 
individuals with CIC in these two studies can be partially attributed to the better care 
coordination in these systems. 
However, the findings from this study is inconsistent with the findings from the study 
using the INTERMED classification system for case complexity which found that among 
individuals with T2DM, greater complexity was associated with higher HbA1c values (Fischer et 
al., 2000). The INTERMED classification system utilized different factors such as biological, 
psychosocial and health care related aspects of T2DM to classify patient complexity and had 
only 61 patients in the study. The results presented were in the preliminary forms and it required 
further validation. Hence, it is possible that due to different classification system used to 
determine patient complexity, greater risk of poor diabetes control among individuals with 
higher complexity was observed.   
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Strengths and Limitations 
 Strengths of this study include the use of large sample size, nationwide sample of 
commercially insured elderly individuals, exhaustive list of variables, availability of laboratory 
values and use of a robust study design. 
 As with other studies, this study also has limitations. Findings from this study cannot be 
generalizable to other populations or settings (e.g. fee-for-service Medicare beneficiaries). 
Laboratory values are available for only one-third of the population. Unmeasured confounders 
such lifestyle risk factors (e.g. body mass index and smoking status), physician specialty, 
duration and severity of PD could influence the study outcomes.  
CONCLUSION 
 To the best of author‟s knowledge, this is the first study to examine the effect or 
influence of the presence of a chronic illness with complexity such as PD on the process and 
outcomes of diabetes care. Individuals with PD and diabetes were less likely to achieve ADA 
recommended annual HbA1c and lipid testing goals compared to those with diabetes but without 
PD. Future research needs to explore the reasons for lower rates of HbA1C and lipid testing 
among elderly individuals with T2DM and PD. However, among individuals with CIC, the 
intermediate glycemic and lipid outcomes were better compared to those without CIC. These 
findings suggest that the integrated delivery system of Medicare Advantage plans may be 
beneficial to elderly with CIC. 
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Table 1: Distribution of Matching Variables before and after Propensity Score Matching 
Humana Medicare Advantage Part-D Database (2007-2011) 
  Before Matching  After Matching 
2007 
 
  PD No PD  PD No PD  
  N= 775 N= 101,306 Sig N= 775 N= 2,325 Sig 
Age  (Mean ± SD) 74.57 (± 4.96) 72.56 (± 5.02) *** 74.57 (± 4.96) 74.56 (± 4.95)  
DCSI Total (Mean ± SD) 3.42 (± 2.38) 2.22 (± 2.11) *** 3.42 (± 2.38) 3.42 (± 2.38)  
Gender   ***    
 Male (N, %) 461 (59.48%) 47,844 (47.23%)  461 (59.48%) 1,385 (59.57%)  
 Female (N, %) 314 (40.52%) 53,462 (52.77%)  314 (40.52%) 940 (40.43%)  
2008 
 
  PD No PD  PD No PD  
  N= 949 N= 120,136 Sig N= 571 N= 1,713 Sig 
Age  (Mean ± SD) 75.16 (± 5.18) 72.80 (± 5.19) *** 74.95 (± 5.32) 74.94 (± 5.32)  
DCSI Total (Mean ± SD) 3.46 (± 2.34) 2.31 (± 2.15) *** 3.42 (± 2.33) 3.42 (± 2.34)  
Gender   ***    
 Male (N, %) 535 (56.38%) 56,985 (47.43%)  307 (53.77%) 919 (53.65%)  
 Female (N, %) 414 (43.62%) 63,151 (52.57%)  264 (46.23%) 794 (46.35%)  
2009 
 
  PD No PD  PD No PD  
  N= 1,208 N= 144,290 Sig N= 667 N= 2,001 Sig 
Age  (Mean ± SD) 75.24 (± 5.48) 73.00 (± 5.37) *** 74.54 (± 5.61) 74.59 (± 5.60)  
DCSI Total (Mean ± SD) 3.59 (± 2.38) 2.44 (± 2.19) *** 3.57 (± 2.47) 3.54 (± 2.41)  
Gender   ***    
 Male (N, %) 710 (58.77%) 68,650 (47.58%)  382 (57.27%) 1,153 (57.62%)  
 Female (N, %) 498 (41.23%) 75,640 (52.42%)  285 (42.73%) 848 (42.38%)  
2010 
 
  PD No PD  PD No PD  
  N= 1,384 N= 170,941 Sig N= 714 N= 2,142 Sig 
Age  (Mean ± SD) 75.43 (± 5.63) 73.20 (± 5.48) *** 74.77 (± 5.88) 74.79 (± 5.87)  
DCSI Total (Mean ± SD) 3.66 (± 2.43) 2.49 (± 2.21) *** 3.65 (± 2.44) 3.64 (± 2.42)  
Gender   ***    
 Male (N, %) 815 (58.89%) 80,924 (47.34%)  416 (58.26%) 1,250 (58.36%)  
 Female (N, %) 569 (41.11%) 90,017 (52.66%)  298 (41.74%) 892 (41.64%)  
Note: This table presents the matching variable distribution before and after propensity score matching by individual 
year. 
*** P < 0.001; ** 0.001 ≤ P < .01; * 0.01 ≤ P < 0.05 
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Table 2: Distribution of matching variables after Propensity Score Matching 
Humana Medicare Advantage Part-D Database (2007-2011 stacked) 
  
PD No PD 
  
  
N= 2,703 N= 8,109 p-value Sig 
Age  (Mean ± SD) 74.67 (± 5.44) 74.67 (± 5.44) 1.0000 
 DCSI Total (Mean ± SD) 3.46 (± 2.34) 3.46 (± 2.34) 1.0000 
 Gender 




Male (N, %) 1,554 (57.5%) 4,662 (57.5%) 
 
 
Female (N, %) 1,149 (42.5%) 3,447 (42.5%) 
 Note: Based on propensity score matched data (matched on baseline age, gender and Diabetes Complications 
Severity Index) from Humana Medicare Prescription-Drug Plan of 10,812 elderly Medicare beneficiaries 
(2,703cases with Parkinson‟s disease and type-2 Diabetes Mellitus and 8,109 controls with only type-2 Diabetes 
Mellitus) during the period of January 2007 to December 2011. 
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Table 3: Baseline characteristics of Elderly Medicare Beneficiaries after 
matching 
Humana Medicare Advantage Part-D Database (2007-2011) 
  PD Col % No PD Col % Sig 
Race/Ethnicity     *** 
 White 2,047 75.7 6,025 74.3  
 African American 293 10.8 1,168 14.4  
 Other 169 6.3 446 5.5  
 Unknown 194 7.2 470 5.8  
Region     *** 
 South 1,806 66.8 5,223 64.4  
 Midwest 604 22.3 1,778 21.9  
 Other Region 293 10.8 1,108 13.7  
Plan Type     *** 
 HMO 1,315 48.6 3,648 45.0  
 PFFS 918 34.0 2,536 31.3  
 Others 470 17.4 1,925 23.7  
Donut Hole     *** 
 No DH 1,012 37.4 4,590 56.6  
 Beg DH 1,213 44.9 2,937 36.2  
 Beg/End DH 478 17.7 582 7.2  
DCSI Quintile      
 0 – 0 619 22.9 1,857 22.9  
 1 – 1 421 15.6 1,263 15.6  
 2 – 2 619 22.9 1,857 22.9  
 3 – 4 504 18.6 1,512 18.6  
 5 - 13 540 20.0 1,620 20.0  
Polypharmacy quintile     *** 
 0 – 0 357 13.2 1,644 20.3  
 1 – 1 454 16.8 1,749 21.6  
 2 – 3 539 19.9 1,818 22.4  
 4 – 5 620 22.9 1,570 19.4  
 6 - 31 733 27.1 1,328 16.4  
Urinary Incontinence     *** 
 Yes 280 10.4 353 4.4  
 No 2,423 89.6 7,756 95.6  
Major Depressive Disorder     *** 
 Yes 722 26.7 963 11.9  
 No 1,981 73.3 7,146 88.1  
Cognitive Impairment *** 
 Yes 904 33.4 686 8.5  
 No  1,799 66.6 7,423 91.5  
Dominant Conditions   
 Yes 340 12.6 989 12.2  
 No 2363 87.4 7120 87.8  
Falls and falls risk     *** 
 Yes 268 9.9 354 4.4  
 No 2435 90.1 7755 95.6  
       
Baseline ER visit     *** 
 Yes 1500 55.5 3172 39.1  
 No 1203 44.5 4937 60.9  
       
Contd. 
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Table 3: Baseline characteristics of Elderly Medicare Beneficiaries after 
matching 
Humana Medicare Advantage Part-D Database (2007-2011) 
  PD Col % No PD Col % Sig 
Baseline HH visit     *** 
 Yes 1647 60.9 3736 46.1  
 No 1056 39.1 4373 53.9  
Note: Based on propensity score matched data (matched on baseline age, gender and Diabetes Complications 
Severity Index) from Humana Medicare Prescription-Drug Plan of 10,812 elderly Medicare beneficiaries 
(2,703cases with Parkinson‟s disease and type-2 Diabetes Mellitus and 8,109 controls with only type-2 Diabetes 
Mellitus) during the period of January 2007 to December 2011.  
PD: Parkinson‟s disease; AOR: Adjusted Odds Ratio; ER: Emergency Room; HH: Home Health; HMO: Health 
Maintenance Organization; PFFS: Private Fee for Service; Sig: Significance; LDL: Low Density Lipoprotein; HDL: 
High Density Lipoprotein; Trigly: Triglyceride; yr: Year; chol: Cholesterol. 
Asterisks represent significant group differences in HbA1c testing according to American Diabetes Association 
(ADA) guidelines using conditional logistic regression adjusting for the matched pair design:  
*** P < 0.001; ** 0.001 ≤ P < .01; * 0.01 ≤ P < 0.05 
†Dominant conditions consisted of cancers, end stage renal disease, end stage liver disease, and amputations 
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Table 4: Description of Process of Care and Intermediate Clinical Outcomes 
Humana Medicare Advantage Part D database (2007-2011) 
  
 PD   Col %   No PD   Col %   Sig  
  
N = 2,703 N = 8,109 
  HbA1c Testing  
    
 ***  
 
 Yes           1,722                63.7           5,505           67.90  
 
 
 No              981                36.3           2,604           32.10  
  Lipid Testing  
    
 ***  
 
 Yes           2,174                80.4           6,978           86.10  
 
 
 No             529                19.6           1,131           13.90  
  Nephropathy Screening  
     
 
 Yes           2,027                75.0           6,015           74.20  
 
 
 No             676                25.0           2,094           25.80  
  Intermediate Clinical Outcomes among those with Available Laboratory Values  
  PD No PD  
 HbA1c groups  N= 1,247 N = 3,736 
 
 
 HbA1c >= 8%              174                14.0              604           16.2  
 
 
 HbA1c < 8%           1,073                86.0           3,132           83.8  
  LDL-C groups  N = 559 N = 1938  **  
 
 >= 100 mg/Dl              137                25.0              586           30.2  
 
 
 0<= LDL < 100              422                75.0           1,352           69.8  
  Triglyceride groups  N = 558 N = 1977  *  
 
 trigly>= 150 mg/DL              202                36.0              819           41.4  
 
 
 0<= trigly< 15mg/DL              356                64.0           1,158           58.6  
  Total Cholesterol groups  N = 561 N = 1982  *  
 
 Tot Chol >= 200mg/DL                72                13.0              336           17.0  
 
 
 Tot Chol < 200mg/DL             489                87.0           1,646           83.0  
  HDL-C groups  N = 1157 N = 3676  *  
 
 HDL < 50 mg/Dl              696                60.0           2,364           64.3  
 
 
 HDL >= 50 mg/Dl              461                40.0           1,312           35.7  
        
Note: Based on propensity score matched data (matched on baseline age, gender and Diabetes Complications 
Severity Index) from Humana Medicare Prescription-Drug Plan of 10,812 elderly Medicare beneficiaries (2,703 
cases with Parkinson‟s disease and type-2 Diabetes Mellitus and 8,109 controls with only type-2 Diabetes Mellitus) 
during the period of January 2007 to December 2011 (except the bottom panel).  
PD: Parkinson‟s disease; Sig: Significance; LDL: Low Density Lipoprotein; HDL: High Density Lipoprotein; 
Trigly: Triglyceride; yr: Year; chol: Cholesterol. 
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Table 5: Adjusted Odds Ratios and 95% Confidence Intervals from 
Conditional Logistic Regressions Process of Care Measures as per ADA 
Guidelines 
Humana Medicare Advantage Part D (2007-2011) 
  
AOR 95% CI Sig 
HbA1c Testing 
   
 
PD  0.88 [0.79,0.97] * 
 No PD (Reference Group)    
Lipid Testing 
   
 
PD 0.82 [0.72,0.94] ** 
 No PD (Reference Group)    
Nephropathy Testing 
   
 
PD 0.99 [0.88,1.10] 
  No PD (Reference Group)    
     
Note: Based on propensity score matched data (matched on baseline age, gender and Diabetes Complications 
Severity Index) from Humana Medicare Prescription-Drug Plan of 10,812 elderly Medicare beneficiaries (2,703 
cases with Parkinson‟s disease and type-2 Diabetes Mellitus and 8,109 controls with only type-2 Diabetes Mellitus) 
during the period of January 2007 to December 2011.  
Model adjusted for: Race/Ethnicity, Region, Insurance Plan Type, Donut Hole, Polypharmacy, Urinary 
Incontinence, Cognitive Impairment due to physical conditions, Cognitive Impairment due to mental conditions, 
Falls and Falls Risk, Major Depressive Disorder, Baseline Emergency Room visit, Baseline Home Health visit, 
Dominant conditions (cancers, end stage renal disease, end stage liver disease, and amputations). 
PD: Parkinson‟s disease AOR: Adjusted Odds Ratio; CI: Confidence Interval; Sig: Significance. 
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Table 6: Adjusted Odds Ratios and 95% Confidence Intervals from 
Multinomial Conditional Logistic Regressions on Intermediate 
Outcomes 
Humana Medicare Advantage Part D (2007-2011) 
  
AOR 95% CI Sig 
HbA1c  <8% vs ≥ 8% 
   
 
PD 1.34 [1.10,1.63] ** 
 No PD (Reference Group)    
LDL-C <100 mg/dL vs ≥ 100 mg/dL 
   
 
PD 1.29 [1.06,1.59] * 
 No PD (Reference Group)    
Triglyceride <150mg/dL vs ≥ 150 mg/dl 
   
 
PD 1.31 [1.06,1.62] * 
 No PD (Reference Group)    
HDL-C ≥ 50 mg/dL vs ≥ 50 mg/dL 
   
 
PD  1.20 [1.04,1.39] * 
 No PD (Reference Group)    
Total Cholesterol < 200 mg/dL vs. ≥ 200 
mg/dl 
   
 
PD 1.46 [1.08,1.97] * 
 No PD (Reference Group)    
     
Note: Based on propensity score matched data (matched on baseline age, gender and Diabetes Complications 
Severity Index) from Humana Medicare Prescription-Drug Plan of 10,812 elderly Medicare beneficiaries (2,703 
cases with Parkinson‟s disease and type-2 Diabetes Mellitus and 8,109 controls with only type-2 Diabetes Mellitus) 
during the period of January 2007 to December 2011.  
Model adjusted for: Race/Ethnicity, Region, Insurance Plan Type, Donut Hole, Polypharmacy, Urinary 
Incontinence, Cognitive Impairment due to physical conditions, Cognitive Impairment due to mental conditions, 
Falls and Falls Risk, Major Depressive Disorder, Baseline Emergency Room visit, Baseline Home Health visit, 
Dominant conditions (cancers, end stage renal disease, end stage liver disease, and amputations). 
PD: Parkinson‟s disease; AOR: Adjusted Odds Ratio; CI: Confidence Interval; Sig: Significance; LDL-C: Low 
Density Lipoprotein Cholesterol; HDL-C: High Density Lipoprotein Cholesterol. 
*** P < 0.001; ** 0.001 ≤ P < .01; * 0.01 ≤ P < 0.05 
Reference groups: ≥8% HbA1c; LDL-C ≥ 100mg/dL; Triglyceride ≥ 150mg/dL; LDL-C ≥ 50mg/dL; Total 
Cholesterol ≥ 200mg/dL. 
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Figure 1: Cohort development 
Before Matching 
2007 
PD = 775,  
No PD = 101,306 
 
Pooled (2007-2010) 
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Final cohort 
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Appendix I 
HbA1c testing  
Individuals with HbA1c testing at least two times a year (with a gap of at least one 
month) will be considered as meeting standard of care for diabetes management. HbA1c 
testing will be identified by the following Current Procedural Terminology (CPT) codes. 
a. CPT codes: 83036, 83037 (Source : HEDIS, 2012) 
b. CPT Category II : 3044F, 3045F, 3046F, 3047F (Source : HEDIS, 2012) 
Lipid testing  
Individuals who were tested at least once a year will be considered as meeting standard of 
care for diabetes management. Lipid testing will be identified by the following Current 
Procedural Terminology (CPT) codes.  
a. CPT codes: 80061, 83700, 83701, 83704, 83721, 83715, 83716, 83718, 82465, 
and 84478 (Source: Morrato et al. 2008; HEDIS, 2012)  
b. CPT Category II: 3048F, 3049F, 3050F 
Nephropathy screening 
Individuals who were screened at least once a year for urine albumin and serum 
creatinine will be considered as meeting standard of care for diabetes management. 
Nephropathy screening will be identified using the following Current Procedural 
Terminology (CPT) codes. 
a. CPT codes: 81000, 81001, 81002, 81003, 36800, 36810, 36815, 50300, 50340, 
50360, 50365, 50370, 50380, 90920, 90921, 90924, 90925, 90935, 90937, 90945, 
90947, 90989, 90993, 90997, and 90999 82579 for serum creatinine lab (Mainous 
et al. 2001); 82042, 82043, 82044, 84156 (Source: HEDIS, 2012) 
b. CPT Category II: 3060F, 3061F (Source: HEDIS, 2012) 
  















DISCUSSION & CONCLUSIONS 
SUMMARY OF FINDINGS 
 
The purpose of this dissertation was to use observational data from real-world settings to 
provide a comprehensive view of the burden of illness among elderly individuals with PD. We 
answered three research questions pertaining to the economic impact of both formal and informal 
caregiving burden and the impact of chronic illness with complexity on process and intermediate 
clinical outcomes among elderly individuals with PD. Economic impact of formal caregiving 
burden was assessed by estimating the home healthcare use and expenditures among elderly 
Medicare beneficiaries with PD compared to those without PD. Focusing on a Medicare 
population to assess the impact of economic burden of formal caregiving is appropriate as 
Medicare provides near universal coverage for elderly individuals in the U.S. Economic burden 
of the informal caregiving was estimated by multiplying number of caregiving hours per week by 
the median wage ($10.10/hour) of a household aide. Informal caregiver burden was also 
measured based on three questions on physical strain, emotional stress and financial hardship on 
the informal caregivers. Chronic illness with complexity (CIC) was defined as the co-occurrence 
of PD and type 2 diabetes mellitus (T2DM). It is important to assess the process and intermediate 
outcomes among elderly individuals with CIC as it has been estimated that by 2030, the 
prevalence of both T2DM and PD will increase by approximately two-folds due to the aging 
U.S. population (Dorsey et al. 2007) and will become a major public health concern in the near 
future. Due to the unavailability of a single database that can answer all these research questions, 
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we used a triangulation approach by using data from different sources to answer the research 
questions of this dissertation.  
The first research question of this dissertation was to estimate the excess home healthcare 
use and expenditures among elderly Medicare beneficiaries with PD compared to those without 
PD using the national Medicare 5% claims database (2006-2007). In this aim, we also estimated 
the extent to which the individual-level factors such as predisposing, enabling, need, personal 
health behaviors, and external environmental factors contributed to the differences in home 
healthcare use and expenditures between elderly Medicare beneficiaries with and without PD. 
Elderly Medicare beneficiaries with PD had 13.28 percentage points (PD: No PD:: 22.50% vs. 
9.22%) higher home healthcare use compared to those without PD. Multivariate analysis also 
revealed similar findings with elderly Medicare beneficiaries with PD having greater than two 
times more likelihood to have home healthcare use compared to those without PD. It was 
estimated that the average home healthcare expenditures among elderly Medicare beneficiaries 
(who used home healthcare service) with PD was 1.34 times higher compared to those without 
PD ($6,792 vs. $5,060). Multivariate Ordinary Least Square (OLS) regression analysis showed 
consistent findings. These findings are consistent with previous studies which showed that home 
healthcare use and expenditures among individuals with PD are significantly higher among 
individuals with PD ((Bhattacharjee & Sambamoorthi, 2013; Noyes et al., 2006; Pressley et al., 
2003; Rubenstein, Chrischilles, & Voelker, 1997)). The unique contribution of this study was to 
estimate the extent to which individual-level factors explained the home healthcare use and 
expenditures among elderly Medicare beneficiaries. Approximately 27% of the differences in 
home healthcare use between elderly Medicare beneficiaries with and without PD were 
explained by the predisposing, need, personal health choice and external environmental factors. 
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However, only 11% of the total home healthcare expenditure differences between elderly 
Medicare beneficiaries with and without PD were explained by the individual-level factors used 
in this study. Personal health behaviors such as baseline resource use and need factors such as 
mental and physical health conditions explained the highest proportion of the home healthcare 
use and expenditure differences.  
The second question of this dissertation focused on assessing the informal caregiver 
burden among caregivers of elderly care-recipients with PD compared to the informal caregivers 
of elderly care-recipients without PD using the nationally representative sample of National 
Alliance for Caregivers (2004, 2009). This research question also estimated costs associated with 
providing informal care to elderly individuals with and without PD. The caregiver burden as 
estimated on the computed caregiver scale was similar among individuals with and without PD 
(2.25 vs. 2.21). The average number of caregiving hours per week for care-recipients with PD 
was higher than those without PD (PD:: No PD 27.51 (±35.04) hours: 21.62 (±28.71)). The 
average annual costs of informal caregiving for care-recipients with and without PD were 
approximately $14,448 and $11,355 respectively. However, these differences in terms of number 
of hours of informal caregiving per week and annual costs of informal caregiving were not 
statistically significant. After adjusting for care-recipient, caregiver characteristics and other 
independent variables, caregiver burden and costs did not differ significantly between elderly 
individuals with and without PD. One of the main reasons that we can speculate why we did not 
observe statistically significant differences in formal caregiver burden and costs between these 
two groups in bivariate and multivariate analyses may be the small sample size of the informal 
caregivers of care-recipients with PD (N = 32). A noteworthy finding from this research question 
was the association between the functional status of the care-recipients and caregiver burden. It 
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was observed that ADL and IADL were significantly positively associated with caregiver burden 
in all the three models. Previous studies conducted by Edwards & Ruettinger (2002) and Cifu et 
al., (2006) also observed that higher caregiver burden was associated with increased difficulties 
with ADL performance. Although prior studies have not examined the relationship between 
IADL and caregiver burden, our study documents that increase in the number of difficulties with 
IADLs was also associated with greater caregiver burden.  
The third research of this dissertation used the nation-wide claims database of Humana 
Medicare Advantage Part D enrollees to assess process and intermediate outcomes of diabetes 
care among elderly individuals with CIC (T2DM and PD) compared to those without CIC 
(T2DM without PD). Multivariable conditional logistic regressions revealed that elderly 
individuals with CIC were less likely to meet the annual American Diabetes Association (ADA) 
recommended annual HbA1c and lipid testing compared to elderly individuals without CIC. 
However, multinomial conditional logistic regressions showed that elderly individuals with CIC 
were more likely to achieve glycemic and lipid controls. These findings are consistent with a 
study conducted among elderly veterans, which showed that veterans with CIC were more likely 
to receive overall good outcomes for all 3quality measures (glycemic, blood pressure and low 
density lipoprotein-cholesterol) combined (Woodard, Urech, Landrum, Wang, & Petersen, 
2011). However, these findings were inconsistent with the findings from the study using the 
INTERMED classification system for case complexity which found that among individuals with 
T2DM, greater complexity was associated with higher HbA1c values (Fischer et al., 2000). 
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CONCLUSIONS 
This dissertation assessed the burden of illness among elderly individuals with PD in 
three dimensions of economic burden of formal and informal caregiving, and the impact of CIC 
on the process and intermediate outcomes of care. We found that elderly Medicare beneficiaries 
with PD had significantly higher home healthcare use and expenditures compared to those 
without PD. The differences in home healthcare use and expenditures among elderly Medicare 
beneficiaries with and without PD were mainly explained by personal health behaviors such as 
baseline resource use and need factors such as physical and mental health conditions. In terms of 
economic burden of informal caregiving, we did not observe a significant difference in informal 
caregiving costs between caregivers of elderly individuals with and without PD, despite the costs 
of informal caregiving for elderly individuals with PD being 1.27 times higher than those 
without PD. Individuals with CIC were less likely to achieve ADA recommended annual HbA1c 
and lipid testing goals compared to those without CIC. However, individuals with CIC achieved 
glycemic and lipid control outcomes. Thus, these findings taken together underscore the 
advantage of using an integrated delivery system with better care coordination and providing 
“holistic care approach.” As majority of elderly individuals with PD are community-dwelling, 
novel intervention techniques are needed to be developed to reduce the informal caregiving 
burden. 
IMPLICATIONS OF THE STUDY 
 The findings from our three research questions have significant implications.  
Reducing the cost curve and need for integrated care and following new care models such as 
Patient Centered Medical Homes 
From our first research question, it was observed that the home healthcare use and 
expenditures were significantly higher among elderly Medicare beneficiaries with PD compared 
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to those without PD and personal health behaviors such as the baseline resource use and need 
factors such as physical and mental health conditions had the highest contribution to the 
explained portions of the differences in home healthcare use and expenditures among elderly 
Medicare beneficiaries with and without PD. Findings from this aim have health policy 
implications in terms of reducing cost burden for Medicare, which is the single most important 
payer of healthcare for the elderly. Although less than 5% of total Medicare spending is 
accounted by home healthcare expenditures, Medicare home healthcare spending has grown 
substantially over the past decade. It has been estimated that total Medicare home healthcare 
expenditures increased from by 129% between 2000 and 2010 (Home Healthcare Services-
Chapter 8) and the number of home healthcare users also increased from 2.5 million to 3.4 
million between 2002-2010 (Health Care Spending-Medicare). The Center for Medicare and 
Medicaid Services (CMS) has been exploring ways in which they can contain this escalating 
home healthcare expenditures. As the post-regression decomposition technique results suggest 
that need factors such as physical and mental health conditions which often co-occur, there is a 
need for integrated care and following new care models such as Patient Centered Medical Homes 
to better manage the issue of co-occurring chronic conditions in this geriatric population which 
in turn may lead to better health outcomes and consequent reduction of the escalating cost curve.  
Financial implications of informal caregiving burden and costs 
The second research question of this study provided the first nationally representative 
estimates of costs of informal caregiving of care-recipients with PD. The average annual costs of 
informal caregiving for care-recipients with and without PD were approximately $14,448 and 
$11,355 respectively. The high annual costs of informal care provided to the elderly individuals 
with PD have significant financial implications. As the population of U.S. is aging, and there is 
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an expected subsequent increase in the prevalence of PD, innovative intervention techniques 
need to be developed which can be devoted towards reducing informal caregiving burden and 
also curb the financial burdens of providing informal care.  
Advantages of an Integrated Delivery System 
 From our third research question, we found that individuals with CIC were more likely to 
achieve better intermediate glycemic and lipid outcomes. One of the characteristics of the 
Medicare Advantage plans is that they follow the Integrated Delivery System (IDS) model. In 
the IDS model, the primary physician serves as the gate-keeper and maintains proper referral 
systems. The coordination of care among different types of specialists (Endocrinologists, 
Neurologists etc.) is ensured in the IDS models which in turn could lead to better management of 
individuals with CIC. Hence, this finding further underscores the benefits of following IDS 
where good coordination of care is generally available.  
LIMITATIONS 
Findings from this study should be interpreted with caution as there are some limitations 
associated with this study. For first research question (Aim 1), we did not have information on 
the prescription drug expenditures. Previous research suggests that prescription drug 
expenditures are one of the major drivers of the healthcare expenditures and so estimates from 
the Aim 1 can be under-estimated due to lack of information on prescription drug expenditures. 
The findings from Aim 1 are not generalizable to other populations or settings as we only used 
fee-for-service enrollees and excluded HMO enrollees from the study sample. Users of home 
healthcare may be different from non-users of home health care in unobserved variables. Aim 1 
of this dissertation does not control for such selection bias. The Medicare 5% claims database did 
not have many important and relevant variables that are associated with home healthcare use 
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such as limitations of activities of daily living (ADL) and instrumental activities of daily living 
(IADL). This may lead to underestimation of the explained portion of the estimated differences 
in home healthcare expenditures among individuals with and without PD. However, by using a 
representative sample of Medicare beneficiaries with linked Medicare claims, we are able to 
estimate the extent to which unmeasured factors can underestimate explained portion of the 
differences in expenditures among individuals with and without PD. In terms of our second 
research question (Aim 2) of this dissertation we had some limitations as well. The study sample 
was small with only 32 caregivers of care-recipients with PD. This small sample size may affect 
the power of the analyses. We did not observe significant differences in informal caregiver 
burden in the Aim 2, which can be mostly attributed to the small sample size of the informal 
caregivers of care-recipients with PD. This data did not have information related to clinical 
factors such as presence of physical (e.g. diabetes) and/or mental conditions (e.g. depression, 
anxiety). Adjusting for comorbid conditions may explain more variance in the caregiver burden. 
Moreover, duration and severity of diseases was unavailable. However, ADLs and IADLs may 
serve as global proxies for severity of illness. Additionally, as this is a survey, presence of recall 
bias cannot be ruled out. For our third research question (Aim 3) of this dissertation, we had 
some limitations as well. This Aim used commercially enrolled elderly Medicare beneficiaries 
and hence the findings from this study cannot be generalizable to other populations or settings 
(e.g. fee-for-service Medicare beneficiaries). Moreover, laboratory values are available for only 
one-third of the population. Unmeasured confounders such lifestyle risk factors (e.g. body mass 
index and smoking status), physician specialty, duration and severity of PD could influence the 
study outcomes.  
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FUTURE RESEARCH 
 Future studies should be conducted to answer the questions that were not answered in this 
dissertation, and those studies should also overcome the limitations of this dissertation. Using the 
individual-level factors included in Aim 1of this dissertation, only 27% and 11% of the home 
healthcare use and expenditures differences between elderly Medicare beneficiaries with and 
without PD was explained. Some important factors such as ADL, IADL, and physical and mental 
health status were not available in the Medicare 5% claims database. Intuitively these factors can 
influence the home healthcare use and expenditures and hence future studies should include 
these factors to understand their influence on the home healthcare use and expenditures among 
elderly individuals with PD. In Aim 2 of this dissertation, we did not find an association between 
PD and informal caregiver burden which can be mainly attributed to the small sample size of the 
caregivers of care-recipients with PD. Future studies should try to overcome this problem by 
using a large dataset such as the Health and Retirement Survey linked to Medicare claims, which 
has an additional benefit of including the co-occurring chronic conditions which may also 
influence the informal caregiving burden. In Aim 3 of this dissertation, we found that among 
elderly individuals with PD and type 2 diabetes mellitus (T2DM), the rates of HbA1c and lipid 
testing were significantly lower compared to elderly individuals with T2DM and without PD. 
Future research needs to explore the reasons for lower rates of HbA1C and lipid testing among 
elderly individuals with T2DM and PD and also devise appropriate interventions to overcome 
the barriers to testing.  
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